Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in J Hypertens

Retrieve available abstracts of 836 articles:
HTML format
Text format



Single Articles


    September 2017
  1. JENNINGS GLR
    Antihypertensive therapy: strategic withdrawal or a mandatory life sentence?
    J Hypertens. 2017;35:1778-1779.
    PubMed     Text format    


  2. PERRONE-FILARDI P, Coca A, Galderisi M, Paolillo S, et al
    Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the
    J Hypertens. 2017;35:1727-1741.
    PubMed     Text format     Abstract available


    August 2017
  3. TADIC M, Cuspidi C, Celic V, Pencic-Popovic B, et al
    Nocturnal hypertension and right heart remodeling.
    J Hypertens. 2017 Aug 16. doi: 10.1097/HJH.0000000000001506.
    PubMed     Text format     Abstract available


  4. TSIOUFIS C, Andrikou I, Pruijm M, Ponte B, et al
    Should renal color Doppler ultrasonography be a routine test in newly diagnosed hypertensive patient?
    J Hypertens. 2017 Aug 16. doi: 10.1097/HJH.0000000000001508.
    PubMed     Text format     Abstract available


  5. ZANCHETTI A
    From lifestyle changes to outcomes in hypertension.
    J Hypertens. 2017 Aug 12. doi: 10.1097/HJH.0000000000001542.
    PubMed     Text format    


  6. FU W, Wang C, Zou L, Liu Q, et al
    Association between exposure to noise and risk of hypertension: a meta-analysis of observational epidemiological studies.
    J Hypertens. 2017 Aug 12. doi: 10.1097/HJH.0000000000001504.
    PubMed     Text format     Abstract available


  7. RAMAN MR, Tosakulwong N, Zuk SM, Senjem ML, et al
    Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy.
    J Hypertens. 2017 Aug 10. doi: 10.1097/HJH.0000000000001492.
    PubMed     Text format     Abstract available


  8. GILARDINI L, Lombardi C, Redaelli G, Mattaliano P, et al
    Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines.
    J Hypertens. 2017 Aug 10. doi: 10.1097/HJH.0000000000001507.
    PubMed     Text format     Abstract available


  9. ZANCHETTI A
    Epidemiological, pathophysiological and therapeutic aspects of hypertension.
    J Hypertens. 2017 Aug 5. doi: 10.1097/HJH.0000000000001503.
    PubMed     Text format    


  10. IWASHIMA Y, Fukuda T, Horio T, Hayashi SI, et al
    Association between renal function and outcomes after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.
    J Hypertens. 2017 Aug 3. doi: 10.1097/HJH.0000000000001499.
    PubMed     Text format     Abstract available


  11. BROWN AGM, Houser RF, Mattei J, Mozaffarian D, et al
    Hypertension among US-born and foreign-born non-Hispanic Blacks: National Health and Nutrition Examination Survey 2003-2014 data.
    J Hypertens. 2017 Aug 3. doi: 10.1097/HJH.0000000000001489.
    PubMed     Text format     Abstract available


  12. ALTUNDAG K
    Antihypertensive medication use and breast cancer risk.
    J Hypertens. 2017;35:1722.
    PubMed     Text format    


  13. HOUBEN AJHM, Berendschot TTJM, Grassi G
    Retinal microvascular diameters: normative data and their use in clinical hypertension.
    J Hypertens. 2017;35:1573-1574.
    PubMed     Text format    


  14. DURAND H, Hayes P, Morrissey EC, Newell J, et al
    Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.
    J Hypertens. 2017 Aug 1. doi: 10.1097/HJH.0000000000001502.
    PubMed     Text format     Abstract available


    July 2017
  15. VAN DER SANDE NGC, de Beus E, Bots ML, Voskuil M, et al
    Apparent resistant hypertension and the risk of vascular events and mortality in patients with manifest vascular disease.
    J Hypertens. 2017 Jul 29. doi: 10.1097/HJH.0000000000001494.
    PubMed     Text format     Abstract available


  16. SHI Z, Nicholls SJ, Taylor AW, Magliano DJ, et al
    Early life exposure to Chinese famine modifies the association between hypertension and cardiovascular disease.
    J Hypertens. 2017 Jul 20. doi: 10.1097/HJH.0000000000001496.
    PubMed     Text format     Abstract available


  17. DE LA SIERRA A, Vinyoles E, Banegas JR, Segura J, et al
    Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients.
    J Hypertens. 2017 Jul 18. doi: 10.1097/HJH.0000000000001493.
    PubMed     Text format     Abstract available


  18. OOSTERHUIS NR, Fernandes R, Maicas N, Bae SE, et al
    Extravascular renal denervation ameliorates juvenile hypertension and renal damage resulting from experimental hyperleptinemia in rats.
    J Hypertens. 2017 Jul 12. doi: 10.1097/HJH.0000000000001472.
    PubMed     Text format     Abstract available


  19. NIE X, Dai Y, Tan J, Chen Y, et al
    alpha-Solanine reverses pulmonary vascular remodeling and vascular angiogenesis in experimental pulmonary artery hypertension.
    J Hypertens. 2017 Jul 12. doi: 10.1097/HJH.0000000000001475.
    PubMed     Text format     Abstract available


  20. WINKLER L, Lhuissier FJ, Richalet JP
    Systemic blood pressure at exercise in hypoxia in hypertensive and normotensive patients.
    J Hypertens. 2017 Jul 12. doi: 10.1097/HJH.0000000000001479.
    PubMed     Text format     Abstract available


  21. WANG A, Liu X, Su Z, Chen S, et al
    Two-year changes in proteinuria and risk for myocardial infarction in patients with hypertension: a prospective cohort study.
    J Hypertens. 2017 Jul 3. doi: 10.1097/HJH.0000000000001462.
    PubMed     Text format     Abstract available


  22. TANEMOTO M
    Renal resistive index for resistant hypertension.
    J Hypertens. 2017;35:1525-1526.
    PubMed     Text format    


    June 2017
  23. FITTON CA, Steiner MFC, Aucott L, Pell JP, et al
    In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.
    J Hypertens. 2017 Jun 28. doi: 10.1097/HJH.0000000000001456.
    PubMed     Text format     Abstract available


  24. LE HH, Subtil F, Cerou M, Marchant I, et al
    A sudden death risk score specifically for hypertension: based on 25 648 individual patient data from six randomized controlled trials.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001451.
    PubMed     Text format     Abstract available


  25. WANG Y, Chen L, Wang Y, Qain Y, et al
    Morning hypertension is more common in elderly hypertensive patients with controlled documented office blood pressure in primary care clinics: the Minhang study.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001449.
    PubMed     Text format     Abstract available


  26. MANOHAR S, Thongprayoon C, Cheungpasitporn W, Mao MA, et al
    Associations of rotational shift work and night shift status with hypertension: a systematic review and meta-analysis.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001442.
    PubMed     Text format     Abstract available


  27. ZANCHETTI A
    Diagnostic and therapeutic approaches to hypertension.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001465.
    PubMed     Text format    


  28. KWON LH, Wats K, Rosendorff C
    The effect of vasodilator beta-blockers on renal function in hypertensive patients.
    J Hypertens. 2017 Jun 24. doi: 10.1097/HJH.0000000000001447.
    PubMed     Text format     Abstract available


  29. PAGONAS N, Vlatsas S, Bauer F, Seibert FS, et al
    Aerobic versus isometric handgrip exercise in hypertension: a randomized controlled trial.
    J Hypertens. 2017 Jun 15. doi: 10.1097/HJH.0000000000001445.
    PubMed     Text format     Abstract available


  30. SHANTSILA A, Shantsila E, Beevers DG, Lip GYH, et al
    Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry.
    J Hypertens. 2017 Jun 14. doi: 10.1097/HJH.0000000000001446.
    PubMed     Text format     Abstract available


  31. SPANNELLA F, Giulietti F, Balietti P, Borioni E, et al
    Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.
    J Hypertens. 2017 Jun 13. doi: 10.1097/HJH.0000000000001438.
    PubMed     Text format     Abstract available


  32. ALGHARABLY EAH, Bolbrinker J, Lezius S, Reibis R, et al
    Uromodulin associates with cardiorenal function in patients with hypertension and cardiovascular disease.
    J Hypertens. 2017 Jun 8. doi: 10.1097/HJH.0000000000001432.
    PubMed     Text format     Abstract available


  33. DE LA SIERRA A, Pareja J, Fernandez-Llama P, Armario P, et al
    Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressure.
    J Hypertens. 2017 Jun 7. doi: 10.1097/HJH.0000000000001431.
    PubMed     Text format     Abstract available


  34. SARAFIDIS PA, Bikos A, Loutradis C, Tzikas S, et al
    Diagnosis of tuberous sclerosis complex in a patient referred for uncontrolled hypertension and renal dysfunction: a case highlighting the importance of proper diagnostic work-up of hypertensive patients.
    J Hypertens. 2017 Jun 7. doi: 10.1097/HJH.0000000000001423.
    PubMed     Text format     Abstract available


  35. HOLMQUIST C, Hasselstrom J, Bengtsson Bostrom K, Manhem K, et al
    Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database.
    J Hypertens. 2017 Jun 2. doi: 10.1097/HJH.0000000000001429.
    PubMed     Text format     Abstract available


  36. FENGLER K, Hollriegel R, Okon T, Stiermaier T, et al
    Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
    J Hypertens. 2017;35:1310-1317.
    PubMed     Text format     Abstract available


  37. LI Y, Qin X, Luo L, Wang B, et al
    Folic acid therapy reduces the risk of mortality associated with heavy proteinuria among hypertensive patients.
    J Hypertens. 2017;35:1302-1309.
    PubMed     Text format     Abstract available


  38. JARDIM TV, Reiger S, Abrahams-Gessel S, Gomez-Olive FX, et al
    Hypertension management in a population of older adults in rural South Africa.
    J Hypertens. 2017;35:1283-1289.
    PubMed     Text format     Abstract available


  39. KAWADA T
    Blood pressure control in hypertensive patients with chronic kidney disease.
    J Hypertens. 2017;35:1327-1328.
    PubMed     Text format    


  40. KAHAN T, Spaak J
    Potential of folate supplementation to reduce mortality in hypertensive patients.
    J Hypertens. 2017;35:1168-1169.
    PubMed     Text format    


  41. KJELDSEN SE, Os I
    Interventions to improve adherence of antihypertensive medication in African-Americans.
    J Hypertens. 2017;35:1164-1165.
    PubMed     Text format    


    May 2017
  42. PRUIJM M, Lu Y, Megdiche F, Piskunowicz M, et al
    Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.
    J Hypertens. 2017 May 29. doi: 10.1097/HJH.0000000000001406.
    PubMed     Text format     Abstract available



  43. Guidelines on the management of arterial hypertension and related comorbidities in Latin America.
    J Hypertens. 2017 May 17. doi: 10.1097/HJH.0000000000001418.
    PubMed     Text format    


  44. GILES TD, Cockcroft JR, Pitt B, Jakate A, et al
    Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.
    J Hypertens. 2017 May 15. doi: 10.1097/HJH.0000000000001412.
    PubMed     Text format     Abstract available


  45. VAN MIDDELAAR T, van Vught LA, van Charante EPM, Eurelings LSM, et al
    Lower dementia risk with different classes of antihypertensive medication in older patients.
    J Hypertens. 2017 May 13. doi: 10.1097/HJH.0000000000001411.
    PubMed     Text format     Abstract available


  46. WANG L, Zhu Q, Lu A, Liu X, et al
    Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin-angiotensin system.
    J Hypertens. 2017 May 13. doi: 10.1097/HJH.0000000000001378.
    PubMed     Text format     Abstract available


  47. ZHANG P, Wang H, Sun L, Zhang J, et al
    Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: a randomized double-blind trial.
    J Hypertens. 2017 May 13. doi: 10.1097/HJH.0000000000001407.
    PubMed     Text format     Abstract available


  48. HAMDIDOUCHE I, Jullien V, Boutouyrie P, Billaud E, et al
    Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    J Hypertens. 2017 May 12. doi: 10.1097/HJH.0000000000001402.
    PubMed     Text format     Abstract available


  49. PONTO KA, Werner DJ, Wiedemer L, Laubert-Reh D, et al
    Retinal vessel metrics: normative data and their use in systemic hypertension: results from the Gutenberg Health Study.
    J Hypertens. 2017 May 12. doi: 10.1097/HJH.0000000000001380.
    PubMed     Text format     Abstract available


  50. VAN DER WARDT V, Harrison JK, Welsh T, Conroy S, et al
    Withdrawal of antihypertensive medication: a systematic review.
    J Hypertens. 2017 May 9. doi: 10.1097/HJH.0000000000001405.
    PubMed     Text format     Abstract available


  51. YUSUFALI AM, Khatib R, Islam S, Alhabib KF, et al
    Prevalence, awareness, treatment and control of hypertension in four Middle East countries.
    J Hypertens. 2017 May 8. doi: 10.1097/HJH.0000000000001326.
    PubMed     Text format     Abstract available



  52. Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats: Retraction.
    J Hypertens. 2017;35:1129.
    PubMed     Text format    


  53. HAMDIDOUCHE I, Boutouyrie P
    Is renal denervation an alternative or a complement to aldosterone antagonists in treatment of resistant hypertension?
    J Hypertens. 2017;35:955-957.
    PubMed     Text format    


  54. DOUMAS M, Stavropoulos K, Imprialos K
    Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?
    J Hypertens. 2017;35:950-952.
    PubMed     Text format    


  55. HEAGERTY AM
    Changes in small artery structure in hypertension: ready for prognostic translation?
    J Hypertens. 2017;35:945-946.
    PubMed     Text format    


  56. LEE CJ, Hwang J, Oh J, Lee SH, et al
    Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study.
    J Hypertens. 2017;35 Suppl 1:S41-S49.
    PubMed     Text format     Abstract available


  57. TIMASHEVA Y, Nasibullin T, Imaeva E, Erdman V, et al
    Genetic determinants of essential hypertension in the population of Tatars from Russia.
    J Hypertens. 2017;35 Suppl 1:S16-S23.
    PubMed     Text format     Abstract available


  58. ZANCHETTI A
    Therapeutic approaches, age and ethnicity in hypertension.
    J Hypertens. 2017 May 1. doi: 10.1097/HJH.0000000000001404.
    PubMed     Text format    


  59. CHIA YC, Ching SM, Lim HM
    Visit-to-visit SBP variability and cardiovascular disease in a multiethnic primary care setting: 10-year retrospective cohort study.
    J Hypertens. 2017;35 Suppl 1:S50-S56.
    PubMed     Text format     Abstract available


  60. MURATA M, Kitamura T, Tamada D, Mukai K, et al
    Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.
    J Hypertens. 2017;35:1079-1085.
    PubMed     Text format     Abstract available


  61. TSIOUFIS C, Dimitriadis K, Kasiakogias A, Kalos T, et al
    Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome.
    J Hypertens. 2017;35:1100-1108.
    PubMed     Text format     Abstract available


    April 2017
  62. COCA A, Agabiti-Rosei E, Cifkova R, Manolis AJ, et al
    The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension.
    J Hypertens. 2017 Apr 26. doi: 10.1097/HJH.0000000000001390.
    PubMed     Text format     Abstract available


  63. VOGIATZAKIS N, Tsioufis C, Georgiopoulos G, Thomopoulos C, et al
    Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis.
    J Hypertens. 2017 Apr 25. doi: 10.1097/HJH.0000000000001391.
    PubMed     Text format     Abstract available


  64. KURDI AI, Chen LC, Elliott RA
    Exploring factors associated with patients' adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom.
    J Hypertens. 2017 Apr 22. doi: 10.1097/HJH.0000000000001382.
    PubMed     Text format     Abstract available


  65. MENDEZ-LOPEZ I, Bomfim GH, Musial DC, Arranz-Tagarro JA, et al
    Altered mitochondrial function, capacitative calcium entry and contractions in the aorta of hypertensive rats.
    J Hypertens. 2017 Apr 11. doi: 10.1097/HJH.0000000000001360.
    PubMed     Text format     Abstract available


  66. RUBATTU S, Cotugno M, Bianchi F, Sironi L, et al
    A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines.
    J Hypertens. 2017 Apr 10. doi: 10.1097/HJH.0000000000001374.
    PubMed     Text format     Abstract available


  67. LEONE D, Tosello F, Faletti R, Schivazappa G, et al
    Accuracy of transthoracic echocardiography in the assessment of proximal aortic diameter in hypertensive patients: comparison with cardiac magnetic resonance.
    J Hypertens. 2017 Apr 10. doi: 10.1097/HJH.0000000000001381.
    PubMed     Text format     Abstract available


  68. PENG H, Yeh F, de Simone G, Best LG, et al
    Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians: findings from the Strong Heart Study.
    J Hypertens. 2017 Apr 4. doi: 10.1097/HJH.0000000000001375.
    PubMed     Text format     Abstract available


  69. WANG JG, Kario K, Park JB, Chen CH, et al
    Morning blood pressure monitoring in the management of hypertension.
    J Hypertens. 2017 Apr 4. doi: 10.1097/HJH.0000000000001379.
    PubMed     Text format     Abstract available


  70. RAVASSA S, Lopez B, Querejeta R, Echegaray K, et al
    Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
    J Hypertens. 2017;35:853-861.
    PubMed     Text format     Abstract available


  71. FERNANDEZ-MENDOZA J, He F, Vgontzas AN, Liao D, et al
    Objective short sleep duration modifies the relationship between hypertension and all-cause mortality.
    J Hypertens. 2017;35:830-836.
    PubMed     Text format     Abstract available


  72. VELOUDI P, Blizzard CL, Srikanth VK, Breslin M, et al
    Age-dependent changes in blood pressure over consecutive office measurements: impact on hypertension diagnosis and implications for international guidelines.
    J Hypertens. 2017;35:753-760.
    PubMed     Text format     Abstract available


  73. RIM TH, Lee SY, Kim SH, Kim SS, et al
    Increased incidence of open-angle glaucoma among hypertensive patients: an 11-year nationwide retrospective cohort study.
    J Hypertens. 2017;35:729-736.
    PubMed     Text format     Abstract available


  74. HUANG Y, Huang W, Mai W, Cai X, et al
    White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.
    J Hypertens. 2017;35:677-688.
    PubMed     Text format     Abstract available


  75. ZANCHETTI A
    Predisposing factors, accompanying diseases and complications of hypertension.
    J Hypertens. 2017;35:655-656.
    PubMed     Text format    


  76. BURNIER M
    Is there a place for a dual angiotensin receptor-neprilysin inhibitor in the treatment of hypertension?
    J Hypertens. 2017;35:726-728.
    PubMed     Text format    


  77. KOLLIAS A, Protogerou AD, Stergiou GS
    Antihypertensive treatment-induced changes in arterial stiffness: Which artery? Which method?
    J Hypertens. 2017;35:721-725.
    PubMed     Text format    


  78. PERSEGHIN G, Manzoni G, Grassi G
    Hypertension and hepatic triglycerides content: a two (multi)-faceted clinical challenge?
    J Hypertens. 2017;35:715-717.
    PubMed     Text format    


  79. MANCIA G
    White-coat hypertension: growing evidence in favour of its adverse prognostic significance.
    J Hypertens. 2017;35:710-712.
    PubMed     Text format    


    March 2017
  80. ZANCHETTI A
    Treatment adherence and hypertension in the elderly.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001351.
    PubMed     Text format    


  81. BAHADORAN Z, Mirmiran P, Momenan AA, Azizi F, et al
    Allium vegetable intakes and the incidence of cardiovascular disease, hypertension, chronic kidney disease, and type 2 diabetes in adults: a longitudinal follow-up study.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001356.
    PubMed     Text format     Abstract available


  82. CORRAO G, Rea F, Monzio Compagnoni M, Merlino L, et al
    Protective effects of antihypertensive treatment in patients aged 85 years or older.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001323.
    PubMed     Text format     Abstract available


  83. YAO QP, Xie ZW, Wang KX, Zhang P, et al
    Profiles of long noncoding RNAs in hypertensive rats: long noncoding RNA XR007793 regulates cyclic strain-induced proliferation and migration of vascular smooth muscle cells.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001304.
    PubMed     Text format     Abstract available


  84. POULTER NR, Schutte AE, Tomaszewski M, Lackland DT, et al
    May Measurement Month: a new joint global initiative by the International Society of Hypertension and the World Hypertension League to raise awareness of raised blood pressure.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001346.
    PubMed     Text format     Abstract available


  85. MOURAD JJ, Amodeo C, de Champvallins M, Brzozowska-Villatte R, et al
    Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001359.
    PubMed     Text format     Abstract available


  86. MUIESAN ML, Salvetti M, Paini A, Riviera M, et al
    Ocular fundus photography with a smartphone device in acute hypertension.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001354.
    PubMed     Text format     Abstract available


  87. HAMDIDOUCHE I, Jullien V, Boutouyrie P, Billaud E, et al
    Drug adherence in hypertension: from methodological issues to cardiovascular outcomes.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001299.
    PubMed     Text format     Abstract available


  88. KAZE AD, Schutte AE, Erqou S, Kengne AP, et al
    Prevalence of hypertension in older people in Africa: a systematic review and meta-analysis.
    J Hypertens. 2017 Mar 6. doi: 10.1097/HJH.0000000000001345.
    PubMed     Text format     Abstract available


  89. KAWADA T
    Thiazide diuretics and fracture in patients with hypertension.
    J Hypertens. 2017;35:645-646.
    PubMed     Text format    


  90. HERING D, Grassi G
    Prognostic significance of masked tachycardia in hypertension: evidence from a prospective international registry.
    J Hypertens. 2017;35:468-470.
    PubMed     Text format    


  91. KOCH SE, Mann A, Jones S, Robbins N, et al
    Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation.
    J Hypertens. 2017;35:602-611.
    PubMed     Text format     Abstract available


  92. TZOURIO C, Hanon O, Godin O, Soumare A, et al
    Impact of home blood pressure monitoring on blood pressure control in older individuals: a French randomized study.
    J Hypertens. 2017;35:612-620.
    PubMed     Text format     Abstract available


  93. CHA RH, Lee H, Lee JP, Kang E, et al
    Changes of blood pressure patterns and target organ damage in patients with chronic kidney disease: results of the APrODiTe-2 study.
    J Hypertens. 2017;35:593-601.
    PubMed     Text format     Abstract available


    February 2017
  94. ZANCHETTI A
    Problems of antihypertensive management: diabetes mellitus, ethnic differences, organ damage and resistance to treatment.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001334.
    PubMed     Text format    


  95. PARK SK, Kim WJ, Lee DY, Lee SY, et al
    Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001340.
    PubMed     Text format     Abstract available


  96. ZHANG Z, Li Z, Cao K, Fang D, et al
    Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001325.
    PubMed     Text format     Abstract available


  97. JIN L, Lin MQ, Piao ZH, Cho JY, et al
    Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2.
    J Hypertens. 2017 Feb 22. doi: 10.1097/HJH.0000000000001327.
    PubMed     Text format     Abstract available


  98. FRITH E, Loprinzi PD
    Physical activity and cognitive function among older adults with hypertension.
    J Hypertens. 2017 Feb 17. doi: 10.1097/HJH.0000000000001311.
    PubMed     Text format     Abstract available


  99. UITERWIJK R, Staals J, Huijts M, de Leeuw PW, et al
    MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001294.
    PubMed     Text format     Abstract available


  100. NAUMCZYK P, Sabisz A, Witkowska M, Graff B, et al
    Compensatory functional reorganization may precede hypertension-related brain damage and cognitive decline: a functional magnetic resonance imaging study.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001293.
    PubMed     Text format     Abstract available


  101. XU T, Zhang Y, Bu X, Wang D, et al
    Blood pressure reduction in acute ischemic stroke according to time to treatment: a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trial.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001288.
    PubMed     Text format     Abstract available


  102. SARAFIDIS PA, Persu A, Agarwal R, Burnier M, et al
    Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the
    J Hypertens. 2017 Feb 2. doi: 10.1097/HJH.0000000000001283.
    PubMed     Text format     Abstract available


  103. DE SOCIO GV, Ricci E, Maggi P, Parruti G, et al
    Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study.
    J Hypertens. 2017;35:409-416.
    PubMed     Text format     Abstract available


  104. SATOH A, Arima H, Ohkubo T, Nishi N, et al
    Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010.
    J Hypertens. 2017;35:401-408.
    PubMed     Text format     Abstract available


  105. PEKARSKIY SE, Baev AE, Mordovin VF, Semke GV, et al
    Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertension.
    J Hypertens. 2017;35:369-375.
    PubMed     Text format     Abstract available


  106. GARCIA ML, Pontes RB, Nishi EE, Ibuki FK, et al
    The antioxidant effects of green tea reduces blood pressure and sympathoexcitation in an experimental model of hypertension.
    J Hypertens. 2017;35:348-354.
    PubMed     Text format     Abstract available


  107. MONNIER A, Garnier P, Quirie A, Pernet N, et al
    Effect of short-term exercise training on brain-derived neurotrophic factor signaling in spontaneously hypertensive rats.
    J Hypertens. 2017;35:279-290.
    PubMed     Text format     Abstract available


  108. PUCCI G, Battista F, Anastasio F, Schillaci G, et al
    Morning pressor surge, blood pressure variability, and arterial stiffness in essential hypertension.
    J Hypertens. 2017;35:272-278.
    PubMed     Text format     Abstract available


  109. XU SL, Trevathan E, Qian Z, Vivian E, et al
    Prenatal and postnatal exposure to pet ownership, blood pressure, and hypertension in children: the Seven Northeastern Cities study.
    J Hypertens. 2017;35:259-265.
    PubMed     Text format     Abstract available


  110. O'ROURKE MF, Adji A
    Managing hypertension in children and adolescents.
    J Hypertens. 2017;35:417.
    PubMed     Text format    


  111. LEYVRAZ M, Santschi V, Chiolero A
    What systematic reviews bring to the field of hypertension.
    J Hypertens. 2017;35:240-242.
    PubMed     Text format    


  112. AKBARI M, Moosazadeh M, Ghahramani S, Tabrizi R, et al
    High prevalence of hypertension among Iranian children and adolescents: a systematic review and meta-analysis.
    J Hypertens. 2017 Feb 1. doi: 10.1097/HJH.0000000000001261.
    PubMed     Text format     Abstract available


    January 2017
  113. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    J Hypertens. 2017 Jan 30. doi: 10.1097/HJH.0000000000001276.
    PubMed     Text format     Abstract available


  114. JOZWIK-PLEBANEK K, Prejbisz A, Wypasek E, Pregowska-Chwala B, et al
    Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.
    J Hypertens. 2017 Jan 30. doi: 10.1097/HJH.0000000000001269.
    PubMed     Text format     Abstract available


  115. DASGUPTA K, Rosenberg E, Joseph L, Trudeau L, et al
    Carotid femoral pulse wave velocity in type 2 diabetes and hypertension: capturing arterial health effects of step counts.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001277.
    PubMed     Text format     Abstract available


  116. LEE CJ, Oh J, Lee SH, Kang SM, et al
    Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001279.
    PubMed     Text format     Abstract available


  117. WEIR MR, Mayo MR, Garza D, Arthur SA, et al
    Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001278.
    PubMed     Text format     Abstract available


  118. DE SOUZA F, Muxfeldt ES, Margallo V, Cortez AF, et al
    Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension: a randomized controlled trial.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001254.
    PubMed     Text format     Abstract available


  119. SALADINI F, Mos L, Fania C, Garavelli G, et al
    Regular physical activity prevents development of hypertension in young people with hyperuricemia.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001271.
    PubMed     Text format     Abstract available


  120. ROSA J, Widimsky P, Waldauf P, Zelinka T, et al
    Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001257.
    PubMed     Text format     Abstract available


  121. SCHNEIDER A, Schwab J, Karg MV, Kalizki T, et al
    Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001264.
    PubMed     Text format     Abstract available


  122. LI X, Wang W, Wang A, Li P, et al
    Vulnerability of the frontal and parietal regions in hypertensive patients during working memory task.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001250.
    PubMed     Text format     Abstract available


  123. VINYOLES E, de la Sierra A, Roso-Llorach A, Banegas JR, et al
    24-h pulse pressure cutoff point definition by office pulse pressure in a population of Spanish older hypertensive patients.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001268.
    PubMed     Text format     Abstract available


  124. RUPPAR TM, Dunbar-Jacob JM, Mehr DR, Lewis L, et al
    Medication adherence interventions among hypertensive black adults: a systematic review and meta-analysis.
    J Hypertens. 2017 Jan 18. doi: 10.1097/HJH.0000000000001260.
    PubMed     Text format     Abstract available


  125. TEDLA YG, Gepner AD, Vaidya D, Colangelo L, et al
    Association between long-term blood pressure control and ten-year progression in carotid arterial stiffness among hypertensive individuals: the multiethnic study of atherosclerosis.
    J Hypertens. 2017 Jan 13. doi: 10.1097/HJH.0000000000001199.
    PubMed     Text format     Abstract available


  126. MYERS MG
    Statistical analysis as a cause of white-coat hypertension.
    J Hypertens. 2017 Jan 12. doi: 10.1097/HJH.0000000000001232.
    PubMed     Text format    


  127. CHU C, Dai Y, Mu J, Yang R, et al
    Associations of risk factors in childhood with arterial stiffness 26 years later: the Hanzhong adolescent hypertension cohort.
    J Hypertens. 2017 Jan 5. doi: 10.1097/HJH.0000000000001242.
    PubMed     Text format     Abstract available


  128. HAMET P, Haloui M, Harvey F, Marois-Blanchet FC, et al
    PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.
    J Hypertens. 2017 Jan 5. doi: 10.1097/HJH.0000000000001241.
    PubMed     Text format     Abstract available


  129. CHUANG YW, Yu MC, Huang ST, Yang CK, et al
    Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study.
    J Hypertens. 2017;35:170-177.
    PubMed     Text format     Abstract available


  130. MALOBERTI A, Meani P, Vallerio P, Varrenti M, et al
    Annexin A5 in treated hypertensive patients and its association with target organ damage.
    J Hypertens. 2017;35:154-161.
    PubMed     Text format     Abstract available


  131. LINZ D, Mancia G, Mahfoud F, Narkiewicz K, et al
    Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry.
    J Hypertens. 2017;35:148-153.
    PubMed     Text format     Abstract available


  132. OH JY, Allison MA, Barrett-Connor E
    Different impacts of hypertension and diabetes mellitus on all-cause and cardiovascular mortality in community-dwelling older adults: the Rancho Bernardo Study.
    J Hypertens. 2017;35:55-62.
    PubMed     Text format     Abstract available


  133. ZANCHETTI A
    Factors and consequences of hypertension.
    J Hypertens. 2017;35:1-2.
    PubMed     Text format    


  134. TANEMOTO M
    Blood pressure reduction after renal denervation in obese hypertensive swine model.
    J Hypertens. 2017;35:199.
    PubMed     Text format    


  135. TEO KK
    Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?
    J Hypertens. 2017;35:36-38.
    PubMed     Text format    


  136. BANEGAS JR
    Mass starvation in early life and adult hypertension in China.
    J Hypertens. 2017;35:29-32.
    PubMed     Text format    


    December 2016
  137. BORGHI C, Paolillo S, Cicero AF, Gargiulo P, et al
    New oral anticoagulants and prevention of thromboembolic events in patients with hypertension and atrial fibrillation: an appraisal.
    J Hypertens. 2016 Dec 28. doi: 10.1097/HJH.0000000000001228.
    PubMed     Text format     Abstract available


  138. BAI YP, Xiao S, Tang YB, Tan Z, et al
    Shear stress-mediated upregulation of GTP cyclohydrolase/tetrahydrobiopterin pathway ameliorates hypertension-related decline in reendothelialization capacity of endothelial progenitor cells.
    J Hypertens. 2016 Dec 28. doi: 10.1097/HJH.0000000000001216.
    PubMed     Text format     Abstract available


  139. WANG JG, Yukisada K, Sibulo A Jr, Hafeez K, et al
    Efficacy and safety of sacubitril/valsartan (LCZ696) add-on to amlodipine in Asian patients with systolic hypertension uncontrolled with amlodipine monotherapy.
    J Hypertens. 2016 Dec 24. doi: 10.1097/HJH.0000000000001219.
    PubMed     Text format     Abstract available


  140. KOTON S, Tanne D, Grossman E
    Prestroke treatment with beta-blockers for hypertension is not associated with severity and poor outcome in patients with ischemic stroke: data from a national stroke registry.
    J Hypertens. 2016 Dec 24. doi: 10.1097/HJH.0000000000001218.
    PubMed     Text format     Abstract available


  141. CHOWDHURY EK, Nelson MR, Jennings GL, Wing LM, et al
    Pet ownership and survival in the elderly hypertensive population.
    J Hypertens. 2016 Dec 22. doi: 10.1097/HJH.0000000000001214.
    PubMed     Text format     Abstract available


  142. STEVENSON ER, Johns EM, Marques FZ, Jackson KL, et al
    Positive allosteric modulation of GABAA receptors attenuates high blood pressure in Schlager hypertensive mice.
    J Hypertens. 2016 Dec 22. doi: 10.1097/HJH.0000000000001210.
    PubMed     Text format     Abstract available


  143. CHEN CW, Kuo TB, Chen CY, Yang CC, et al
    Reduced capacity of autonomic and baroreflex control associated with sleep pattern in spontaneously hypertensive rats with a nondipping profile.
    J Hypertens. 2016 Dec 21. doi: 10.1097/HJH.0000000000001205.
    PubMed     Text format     Abstract available


  144. LIU X, Gu W, Li Z, Lei H, et al
    Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  145. KINTIS K, Tsioufis C, Kasiakogias A, Dimitriadis K, et al
    Noninvasive assessment of haemodynamics in resistant hypertension: the role of the renal resistive index.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  146. BONNET F, Gastaldelli A, Pihan-Le Bars F, Natali A, et al
    Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  147. WANG Z, Chen Z, Wang X, Hao G, et al
    Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  148. PALATINI P, Reboldi G, Beilin LJ, Casiglia E, et al
    Masked tachycardia. A predictor of adverse outcome in hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  149. CUSPIDI C, Facchetti R, Bombelli M, Sala C, et al
    Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: the PAMELA study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  150. FODOR JG, Baker P, Chen L, Leenen FH, et al
    On-treatment blood pressures of older hypertensive patients in Canada: implications for systolic blood pressure intervention trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  151. ZANCHETTI A
    From inflammation to renal denervation in hypertension research.
    J Hypertens. 2016;34:2301-2302.
    PubMed     Text format    


  152. TOMLINSON B, Sritara P, Lopez E, Dalal J, et al
    Hypertension and elevated heart rate: focus on the Asia Pacific region.
    J Hypertens. 2016;34:2330-2332.
    PubMed     Text format    


    November 2016
  153. MANCIA G, Rea F, Cuspidi C, Grassi G, et al
    Blood pressure control in hypertension. Pros and cons of available treatment strategies.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  154. BRUNSTROM M, Eliasson M, Nilsson PM, Carlberg B, et al
    Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  155. ASH GI, Taylor BA, Thompson PD, MacDonald HV, et al
    The antihypertensive effects of aerobic versus isometric handgrip resistance exercise.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  156. WANG T, Li GQ, Zhang HP, Zhang Y, et al
    Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  157. YU EY, Wan EY, Wong CK, Chan AK, et al
    Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  158. DIEDERICHS C, Neuhauser H
    The incidence of hypertension and its risk factors in the German adult population: results from the German National Health Interview and Examination Survey 1998 and the German Health Interview and Examination Survey for Adults 2008-2011.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  159. RAYNER BL, Spence JD
    Hypertension in blacks: insights from Africa.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  160. BRUNO RM, Cartoni G, Stea F, Armenia S, et al
    Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: the CATOD study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  161. GORDON RD
    The importance of not overlooking curable hypertension: primary aldosteronism rarely screened for reflecting poor uptake of Endocrine Society Guidelines.
    J Hypertens. 2016;34:2143-4.
    PubMed     Text format    


  162. SCHMITZ B, Brand SM
    Uric acid and essential hypertension: the endothelial connection.
    J Hypertens. 2016;34:2138-9.
    PubMed     Text format    


    October 2016
  163. SECCIA TM, Caroccia B, Calo LA
    Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  164. CUNHA AR, D'El-Rei J, Medeiros F, Umbelino B, et al
    Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  165. MOSS JG, Belli AM, Coca A, Lee M, et al
    Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  166. THOMSEN LC, Mccarthy NS, Melton PE, Cadby G, et al
    The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  167. ROUSH GC, Amante B, Singh T, Ayele H, et al
    Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  168. BOHM M, Ukena C, Ewen S, Linz D, et al
    Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  169. MENDES M, Dubourg J, Blanchard A, Bergerot D, et al
    Copeptin is increased in resistant hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  170. JACKSON CA, Pathirana T, Gardiner PA
    Depression, anxiety and risk of hypertension in mid-aged women: a prospective longitudinal study.
    J Hypertens. 2016;34:1959-1966.
    PubMed     Text format     Abstract available


    September 2016
  171. KULCHAITANAROAJ P, Brooks JM, Chaiyakunapruk N, Goedken AM, et al
    Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  172. CAMACHO PA, Gomez-Arbelaez D, Molina DI, Sanchez G, et al
    Social disparities explain differences in hypertension prevalence, detection and control in Colombia.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  173. NAPOLI C, Omboni S, Borghi C
    Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  174. CARRARA D, Bruno RM, Bacca A, Taddei S, et al
    Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  175. YU C, Wang J, Li Y, Han X, et al
    Exposure to the Chinese famine in early life and hypertension prevalence risk in adults.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  176. SCHEEPERS LE, Wei FF, Stolarz-Skrzypek K, Malyutina S, et al
    Xanthine oxidase gene variants and their association with blood pressure and incident hypertension: a population study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  177. SVEDMYR S, Zou D, Sommermeyer D, Ficker JH, et al
    Vascular stiffness determined from a nocturnal digital pulse wave signal: association with sleep, sleep-disordered breathing, and hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  178. ZAMAMI R, Kohagura K, Miyagi T, Kinjyo T, et al
    Modification of the impact of hypertension on proteinuria by renal arteriolar hyalinosis in nonnephrotic chronic kidney disease.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  179. OTT C, Mahfoud F, Schmid A, Ewen S, et al
    The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  180. MAIDA KD, Vieira S, Gastaldi AC, Bezerra VB, et al
    Amlodipine and enalapril promote distinct effects on cardiovascular autonomic control in spontaneously hypertensive rats: the role of aerobic physical training.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  181. YAN W, Li X, Zhang Y, Niu D, et al
    Reevaluate secular trends of body size measurements and prevalence of hypertension among Chinese children and adolescents in past two decades.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  182. MARTINEZ-AGUAYO A, Campino C, Baudrand R, Carvajal CA, et al
    Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
    J Hypertens. 2016;34:1808-14.
    PubMed     Text format     Abstract available


  183. CALHOUN DA
    Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertension.
    J Hypertens. 2016;34:1701-3.
    PubMed     Text format    


  184. CUSPIDI C, Sala C, Grassi G
    ECG left atrial abnormality: a marker of stroke prediction in hypertension.
    J Hypertens. 2016;34:1698-700.
    PubMed     Text format    


  185. JORDAN J, Toplak H, Grassi G, Yumuk V, et al
    Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure.
    J Hypertens. 2016;34:1678-88.
    PubMed     Text format     Abstract available


  186. ZANCHETTI A
    Consensus documents and challenges in hypertension research.
    J Hypertens. 2016;34:1663-4.
    PubMed     Text format    


  187. PARREIRA LB, Jardim PC, Sousa AL, Jardim TS, et al
    [OP.8A.06] CARDIAC REHABILITATION IN HYPERTENSIVE PATIENTS: COMPARISON BETWEEN TWO PROTOCOLS.
    J Hypertens. 2016;34 Suppl 2:e99.
    PubMed     Text format     Abstract available


  188. MOS L, Fania C, Saladini F, Mazzer A, et al
    [OP.8A.05] REGULAR PHYSICAL ACTIVITY ATTENUATES THE ASSOCIATION BETWEEN COFFEE CONSUMPTION AND CARDIOVASCULAR EVENTS IN HYPERTENSION. THE HARVEST.
    J Hypertens. 2016;34 Suppl 2:e99.
    PubMed     Text format     Abstract available


  189. MILLEN A, Woodiwiss A, Norton GR
    [OP.8A.02] POST-EXERCISE EFFECTS ON AORTIC WAVE REFLECTION DERIVED FROM WAVE SEPARATION ANALYSIS IN PRE-HYPERTENSIVES AND HYPERTENSIVES: COMPARISON WITH CHANGES IN AUGMENTATION INDEXES.
    J Hypertens. 2016;34 Suppl 2:e98.
    PubMed     Text format     Abstract available


  190. MENDES P, Martinho R, Leite S, Leite-Moreira A, et al
    [OP.8A.01] EXERCISE-INDUCED HYPERTENSION AND CARDIAC HYPERTROPHY IN EPINEPHRINE-DEFICIENT MICE.
    J Hypertens. 2016;34 Suppl 2:e98.
    PubMed     Text format     Abstract available


  191. EIKELIS N, Hering D, Marusic P, Walton A, et al
    [OP.7D.10] THE EFFECT OF RENAL DENERVATION ON ADIPOKINES IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e97.
    PubMed     Text format     Abstract available


  192. ROSA J, Widimsky P, Waldauf P, Lambert L, et al
    [OP.7D.09] THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY.
    J Hypertens. 2016;34 Suppl 2:e96-7.
    PubMed     Text format     Abstract available


  193. KASIAKOGIAS A, Tsioufis C, Kordalis A, Dimitriadis K, et al
    [OP.7D.08] SEVERE RESISTANT HYPERTENSION EXHIBITS THE GREATEST CARDIOVASCULAR RISK AMONG TREATED UNCONTROLLED HYPERTENSIVES: A 4-YEAR FOLLOW-UP STUDY.
    J Hypertens. 2016;34 Suppl 2:e96.
    PubMed     Text format     Abstract available


  194. MEGDICHE F, Vakilzadeh N, Maillard M, Grouzmann E, et al
    [OP.7D.04] CHANGES IN RENAL HEMODYNAMIC AND TUBULAR SODIUM HANDLING ONE YEAR AFTER TRANSCATHETER RENAL DENERVATION IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e95.
    PubMed     Text format     Abstract available


  195. SANDERS M, de Jager R, Bots M, Lobo M, et al
    [OP.7D.03] RENAL DENERVATION IN HYPERTENSIVE PATIENTS NOT ON BLOOD PRESSURE LOWERING DRUGS.
    J Hypertens. 2016;34 Suppl 2:e94-5.
    PubMed     Text format     Abstract available


  196. DUBOURG J, Mendes M, Blanchard A, Frank M, et al
    [OP.7D.02] INCREASE IN PLASMA COPEPTIN CONCENTRATION IN PATIENTS WITH CONFIRMED RESISTANT ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e94.
    PubMed     Text format     Abstract available


  197. RIMPELA J, Hiltunen TP, Fyhrquist F, Kontula KK, et al
    [OP.7C.10] IDENTIFICATION OF GENE VARIANTS ASSOCIATED WITH ANTIHYPERTENSIVE RESPONSES TO BETA BLOCKERS AND LOSARTAN.
    J Hypertens. 2016;34 Suppl 2:e92-3.
    PubMed     Text format     Abstract available


  198. SIEDLINSKI M, Szczepaniak P, Nosalski R, Ludwig-Galezowska A, et al
    [OP.7C.06] VASCULAR TRANSCRIPTOME PROFILING IDENTIFIES SPHINGOSINE KINASE 1 AS A KEY MODULATOR OF ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e91.
    PubMed     Text format     Abstract available


  199. TENTORI S, Lanzani C, Citterio L, Brioni E, et al
    [OP.7C.03] KLOTHO GENE POLYMORPHISM INTERACTS WITH ADDUCIN-ENDOGENOUS OUABAIN-NA+-K+ ATPASE SYSTEM IN SALT SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e90-1.
    PubMed     Text format     Abstract available


  200. MULE G, Castiglia A, Schillaci MK, Luna C, et al
    [OP.7B.08] INFLUENCE OF GENDER ON THE RELATIONSHIPS BETWEEN NEW INDICES OF ADIPOSITY AND LEFT VENTRICULAR MASS AND HYPERTROPHY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e88.
    PubMed     Text format     Abstract available


  201. BORDICCHIA M, Ceresiani M, Pavani M, Sarzani R, et al
    [OP.7B.04] UP-REGULATION OF THE NATRIURETIC PEPTIDE CLEARANCE RECEPTOR AND INHIBITION OF LIPOLYSIS BY INSULIN: FILLING THE GAP BETWEEN METABOLIC SYNDROME AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e86-7.
    PubMed     Text format     Abstract available


  202. DIMITRIADIS K, Tsioufis C, Andrikou E, Kasiakogias A, et al
    [OP.7B.02] METABOLIC SYNDROME IS ASSOCIATED WITH INCREASED SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND ARTERIAL STIFFNESS IN RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e86.
    PubMed     Text format     Abstract available


  203. LIM K, Barzel B, Burke S, Head G, et al
    [OP.7B.01] NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 2:e86.
    PubMed     Text format     Abstract available


  204. DARABONT R, Tautu O, Ardeleanu M, Dorobantu M, et al
    [OP.7A.10] COMMON AND EMERGENT FACTORS ASSOCIATED WITH HYPERTENSION CONTROL IN ROMANIA.
    J Hypertens. 2016;34 Suppl 2:e84-5.
    PubMed     Text format     Abstract available


  205. VAISSE B, Pannier B, Hanon O, Mourad JJ, et al
    [OP.7A.09] A NATIONWIDE EVALUATION OF BLOOD PRESSURE CONTROL IN FRANCE USING HOME BLOOD PRESSURE MONITORING: THE FRENCH LEAGUE AGAINST HYPERTENSION SURVEY (FLAHS 2015).
    J Hypertens. 2016;34 Suppl 2:e84.
    PubMed     Text format     Abstract available


  206. STERGIOU GS, Margetaki A, Boubouchairopoulou N, Haidich B, et al
    [OP.7A.08] AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION IN GREECE: INTERIM ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e84.
    PubMed     Text format     Abstract available


  207. CARRERE P, Halbert N, Helene-Pelage J, Lang T, et al
    [OP.7A.07] TRENDS IN HYPERTENSION AMONG POOR FRENCH CARIBBEAN, 2003 TO 2014: BETTER BUT STILL NOT GOOD ENOUGH.
    J Hypertens. 2016;34 Suppl 2:e83-4.
    PubMed     Text format     Abstract available


  208. GABBA M, Salinaro F, Mussinelli R, Boldrini M, et al
    [OP.7A.06] TREATING HYPERTENSIVE CRISES BETWEEN GUIDELINES AND REAL-WORLD: AN ANTI-HYPERTENSIVE ROLE OF ANTI-ANXIETY DRUGS?
    J Hypertens. 2016;34 Suppl 2:e83.
    PubMed     Text format     Abstract available


  209. VRDOLJAK A, Ivkovic V, Karanovic S, Dika Z, et al
    [OP.7A.05] TRENDS IN PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN CROATIAN CONTINENTAL RURAL POPULATION - ENAH STUDY.
    J Hypertens. 2016;34 Suppl 2:e83.
    PubMed     Text format     Abstract available


  210. BOKRANTZ T, Schioler L, Ljungman C, Kahan T, et al
    [OP.7A.04] ANTIHYPERTENSIVE DRUGS AND THE RISK OF FEMUR FRACTURE IN HYPERTENSIVE PATIENTS IN SWEDISH PRIMARY HEALTH CARE. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD).
    J Hypertens. 2016;34 Suppl 2:e83.
    PubMed     Text format     Abstract available


  211. SAMJI S, Small HY, Coley S, Mischak H, et al
    [OP.LB.02: 06] INVESTIGATION OF URINARY PEPTIDOME OVER PREGNANCY IN RODENT MODEL OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e80.
    PubMed     Text format     Abstract available


  212. MARAIS L, Boutouyrie P, Khettab H, Boulanger C, et al
    [OP.1C.04] STRUCTURAL AND FUNCTIONAL ARTERIAL ABNORMALITIES IN FIBROMUSCULAR DYSPLASIA ARE IN THE CONTINUUM OF HYPERTENSION: AN IMAGING AND BIOMECHANICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e8-9.
    PubMed     Text format     Abstract available


  213. MITCHELL A, Nokay B, Guberina H, Behlen-Wilm U, et al
    [OP.LB.02.05] A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB AND BOSENTAN - SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL.
    J Hypertens. 2016;34 Suppl 2:e79-80.
    PubMed     Text format     Abstract available


  214. LOBO M, Saxena M, Sobotka PA, Ott C, et al
    [OP.LB.02.04] CENTRAL ILIAC ARTERIOVENOUS ANASTOMOSIS FOR UNCONTROLLED HYPERTENSION: 12 MONTH FOLLOW UP RESULTS OF THE ROX CONTROL HTN RANDOMISED CONTROLLED TRIAL.
    J Hypertens. 2016;34 Suppl 2:e78-9.
    PubMed     Text format     Abstract available


  215. NECHUTOVA H, Soucek M, Brabencova K, Stepanova R, et al
    [OP.LB.02.02] NEUROMODULATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e78.
    PubMed     Text format     Abstract available


  216. HMAZZOU R, Flahault A, Marc Y, Llorens-Cortes C, et al
    [OP.6D.03] MODE OF ACTION OF RB150, AN AMINOPEPTIDASE A INHIBITOR PRODRUG AS A CENTRALLY-ACTING ANTIHYPERTENSIVE AGENT IN DOCA-SALT HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e75.
    PubMed     Text format     Abstract available


  217. BUESS D, Giezendanner S, Henny-Fullin K, Handschin A, et al
    [OP.6C.07] COMPLIANCE WITH ESH/ESC GUIDELINES FOR ARTERIAL HYPERTENSION IN SWISS PRIMARY CARE: PHARMACOLOGICAL THERAPY.
    J Hypertens. 2016;34 Suppl 2:e73-4.
    PubMed     Text format     Abstract available


  218. NEBIERIDZE D, Saricheva A
    [OP.6C.05] THE POSSIBILITY OF IMPROVING THE COMPLIANCE TO THE TREATMENT BY USING OF ELECTRONIC VERSION OF SCORE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e73.
    PubMed     Text format     Abstract available


  219. KARAKAYA G, Van Tielen R, Umbach I
    [OP.6C.02] RISK FACTORS ASSOCIATED WITH MEDICATION NON-COMPLIANCE IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e72.
    PubMed     Text format     Abstract available


  220. KASIAKOGIAS A, Tsioufis C, Athanasakis K, Andrikou E, et al
    [OP.6C.01] REAL-WORLD MEDICATION COMPLIANCE IN A SAMPLE OF PATIENTS RECEIVING ANTIHYPERTENSIVE TREATMENT IN GREECE.
    J Hypertens. 2016;34 Suppl 2:e72.
    PubMed     Text format     Abstract available


  221. BASTOS J, Pires J, Pinto J, Araujo A, et al
    [OP.6B.09] AMONG ALL DATA FROM 24-H BLOOD PRESSURE, NIGHTTIME SYSTOLIC BLOOD PRESSURE HAS THE HIGHEST PREDICTIVE VALUE OF CV EVENTS, STOKE AND HEART ATTACKS IN A PORTUGUESE SAMPLE OF TREATED HYPERTENSIVES PATIENTS FOLLOWED FOR 11,8 +/- 5,1 YEARS.
    J Hypertens. 2016;34 Suppl 2:e71.
    PubMed     Text format     Abstract available


  222. PIETRI P, Vlachopoulos C, Vyssoulis G, Ioakeimidis N, et al
    [OP.1B.08] ASSOCIATION OF APOB/APOA 1 RATIO WITH TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e7.
    PubMed     Text format     Abstract available


  223. MALDONADO J, Pereira T
    [OP.6A.03] PREVALENCE AND DETERMINANTS OF HYPERTENSION IN A COHORT OF 15.049 PORTUGUESE CHILDREN AND ADOLESCENTS. THE AVELEIRA REGISTRY.
    J Hypertens. 2016;34 Suppl 2:e66-7.
    PubMed     Text format     Abstract available


  224. BARRIENTOS G, Uceda A, Sgariglia A, Giardina G, et al
    [OP.5D.06] HYPERTENSION AS A PATERNAL FACTOR INFLUENCES MATERNAL ADAPTATION TO PREGNANCY AND IS ASSOCIATED WITH PLACENTAL INSUFFICIENCY AND FETAL GROWTH RESTRICTION.
    J Hypertens. 2016;34 Suppl 2:e64-5.
    PubMed     Text format     Abstract available


  225. SAMUELSSON A, Pombo JM, Coen CW, Mallard C, et al
    [OP.5D.03] CHRONIC INFLAMMATION DURING PREGNANCY INFLUENCE THE PROGRESSION OF EARLY SYMPATHETIC-MEDIATED HYPERTENSION IN OFFSPRING ARISING FROM MATERNAL OBESITY.
    J Hypertens. 2016;34 Suppl 2:e63.
    PubMed     Text format     Abstract available


  226. MORGAN H, Small HY, Beattie E, McBride MW, et al
    [OP.5D.02] TRANSCRIPTOMIC CHANGES IN EARLY PREGNANCY-ASSOCIATED UTERINE ARTERY REMODELLING IN STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 2:e63.
    PubMed     Text format     Abstract available


  227. SMALL H, Nosalski R, Morgan H, Beattie E, et al
    [OP.5D.01] INHIBITON OF TNF-ALPHA SIGNALLING USING ETANERCEPT IMPROVES DEFICIENT UTERINE ARTERY REMODELLING AND PREGNANCY OUTCOME IN THE STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 2:e63.
    PubMed     Text format     Abstract available


  228. ZVARTAU N, Krikunov A, Semakova A, Bolgova E, et al
    [OP.5C.08] FIVE-YEARS TRENDS IN DEMOGRAPHIC CHCRACTERISTICS OF HYPERTENSIVE PATIENTS REFERRED TO SPECIALIZED CARDIOLOGICAL CENTRE: AGE AND GENDER.
    J Hypertens. 2016;34 Suppl 2:e62.
    PubMed     Text format     Abstract available


  229. PALATINI P, Reboldi P, Pierdomenico S, Eguchi K, et al
    [OP.5C.06] MASKED TACHYCARDIA PREDICTS ADVERSE OUTCOME IN HYPERTENSION. THE ABP-INTERNATIONAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e61.
    PubMed     Text format     Abstract available


  230. CLEMENTI A, Buiatti M, Mussinelli R, Salinaro F, et al
    [OP.5C.03] HIGHER PREVALENCE OF HYPERTENSION IN MIGRANTS IN ITALY: A SNAPSHOT OF THE 2012 AND 2013C WORLD KIDNEY DAY.
    J Hypertens. 2016;34 Suppl 2:e60-1.
    PubMed     Text format     Abstract available


  231. MORISCO C, Meccariello A, Buono F, Orefice G, et al
    [OP.5C.02] MICROALBUMINURIA PREDICTS THE RECURRENCE OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e60.
    PubMed     Text format     Abstract available


  232. CREMER A, Boulestreau R, Gosse P
    [OP.1B.05] OVER-24H CENTRAL PULSE PRESSURE IS SUPERIOR TO PERIPHERAL PULSE PRESSURE FOR CARDIOVASCULAR EVENTS PREDICTION. RESULTS FROM THE BORDEAUX HYPERTENSIVE COHORT.
    J Hypertens. 2016;34 Suppl 2:e6.
    PubMed     Text format     Abstract available


  233. DI PILLA M, Bruno RM, Ghiadoni L, Stea F, et al
    [OP.5B.08] IMPACT OF SEASONALITY AND AIR POLLUTANTS ON CAROTID-FEMORAL PULSE WAVE VELOCITY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e59.
    PubMed     Text format     Abstract available


  234. TERENTES-PRINTZIOS D, Vlachopoulos C, Vyssoulis G, Pietri P, et al
    [OP.5B.06] TOTAL ARTERIAL COMPLIANCE AND TARGET ORGAN DAMAGE IN HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 2:e58.
    PubMed     Text format     Abstract available


  235. GALLO A, Rosenbaum D, Mattina A, Koch E, et al
    [OP.5A.02] SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON HUMAN RETINAL ARTERIOLE REMODELING EVALUATED WITH ADAPTIVE OPTICS CAMERA.
    J Hypertens. 2016;34 Suppl 2:e54.
    PubMed     Text format     Abstract available


  236. MALLAMACI F, Tripepi R, Versace MC, Provenzano F, et al
    [OP.4D.08] DISORDERED SLEEP BREATHING (SDB) IS THE MAJOR DETERMINANT OF NON-DIPPING AND NOCTURNAL HYPERTENSION IN KIDNEY TRANSPLANT PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e53.
    PubMed     Text format     Abstract available


  237. RUAN C, Li Y, Ma Y, Kong LR, et al
    [OP.4D.02] ADIPONECTIN-MEDIATED EPITHILIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL FIBROSIS.
    J Hypertens. 2016;34 Suppl 2:e51.
    PubMed     Text format     Abstract available


  238. DEROSA G, Romano D, D'Angelo A, Maffioli P, et al
    [OP.4C.09] COMPARISON BETWEEN CANRENONE OR HYDROCHLOROTHIAZIDE IN ADDITION TO SARTANS IN HYPERTENSIVE DIABETIC PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e49.
    PubMed     Text format     Abstract available


  239. MAZZA A, Lenti S, Schiavon L, Ramazzina E, et al
    [OP.4C.08] ROLE OF THE FIXED-DOSE TRIPLE COMBINATION THERAPY IN THE MANAGEMENT OF UNCONTROLLED HYPERTENSION: FROM THE RANDOMIZED CLINICAL TRIALS TO CLINICAL PRACTICE.
    J Hypertens. 2016;34 Suppl 2:e49.
    PubMed     Text format     Abstract available


  240. KJELDSEN SE, Okin PM, Devereux RB
    [OP.4C.05] IMPACT OF ACHIEVED SYSTOLIC BLOOD PRESSURE ON RENAL FUNCTION IN HYPERTENSIVE PATIENTS: THE LIFE STUDY.
    J Hypertens. 2016;34 Suppl 2:e48.
    PubMed     Text format     Abstract available


  241. LOBO MD, Montarello J, Saxena M, Jain A, et al
    [OP.4C.04] SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN 1, 2 AND 3 TRIALS.
    J Hypertens. 2016;34 Suppl 2:e48.
    PubMed     Text format     Abstract available


  242. OLIVERAS A, Armario P, Sans L, Clara A, et al
    [OP.4C.02] CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY. THE DENERVHTA STUDY RESULTS.
    J Hypertens. 2016;34 Suppl 2:e47.
    PubMed     Text format     Abstract available


  243. SERAVALLE GL, Brambilla G, Dell'Oro R, Trevano FQ, et al
    [OP.4C.01] ANTIHYPERTENSIVE DRUG TREATMENT FAILS TO NORMALIZE SYMPATHETIC ACTIVITY: MICRONEUROGRAPHIC EVIDENCE AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 2:e47.
    PubMed     Text format     Abstract available


  244. SALVETTI M, Paini A, Rosei CA, Bertacchini F, et al
    [OP.4B.09] CARDIAC ORGAN DAMAGE IN HYPERTENSIVE PATIENTS ACCORDING TO ON-TREATMENT BLOOD PRESSURE VALUES.
    J Hypertens. 2016;34 Suppl 2:e46.
    PubMed     Text format     Abstract available


  245. BOMBELLI M, Seravalle G, Maloberti A, Macchiarulo M, et al
    [OP.4B.08] PROGNOSTIC RELEVANCE OF ELECTROCARDIOGRAPHIC TP-TE INTERVAL IN THE GENERAL AND IN THE HYPERTENSIVE POPULATION: DATA FROM THE PAMELA STUDY.
    J Hypertens. 2016;34 Suppl 2:e46.
    PubMed     Text format     Abstract available


  246. DIPLA K, Triantafyllou A, Koletsos N, Sachpekidis V, et al
    [OP.4B.07] EXAGGERATED BLOOD PRESSURE RESPONSE DURING HANDGRIP EXERCISE IN MASKED HYPERTENSIVE: CAN IT BE USED AS AN ADDITIONAL SCREENING TOOL?
    J Hypertens. 2016;34 Suppl 2:e45-6.
    PubMed     Text format     Abstract available


  247. TADIC M, Cuspidi C, Vukomanovic V, Kocijancic V, et al
    [OP.4B.06] THE IMPACT OF UPDATED LEFT VENTRICULAR GEOMETRY CLASSIFICATION ON RIGHT VENTRICULAR REMODELLING IN A HYPERTENSIVE POPULATION.
    J Hypertens. 2016;34 Suppl 2:e45.
    PubMed     Text format     Abstract available


  248. CATENA C, Colussi GL, Novello M, Nait F, et al
    [OP.4B.05] RELATIONSHIPS BETWEEN ALCOHOL INTAKE AND LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 2:e45.
    PubMed     Text format     Abstract available


  249. MULE' G, Nardi E, Guarino L, Morreale M, et al
    [OP.4B.03] CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e44.
    PubMed     Text format     Abstract available


  250. BONNET B, Jourdan F, Cailar Gd, Fesler P, et al
    [OP.4B.02] NON INVASIVE EVALUATION OF END SYSTOLIC LEFT VENTRICULAR ELASTANCE ACCORDING TO PRESSURE-VOLUME CURVE MODELING DURING EJECTION IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e44.
    PubMed     Text format     Abstract available


  251. TADIC M, Cuspidi C, Vukomanovic V, Pencic B, et al
    [OP.4B.01] LEFT VENTRICULAR MECHANICS IN PATIENTS WITH MASKED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e44.
    PubMed     Text format     Abstract available


  252. DE LA SIERRA A, Pareja J, Armario P, Barrera A, et al
    [OP.4A.10] RENAL DENERVATION VERSUS SPIRONOLACTONE IN RESISTANT HYPERTENSION. EFFECTS ON CIRCADIAN PATTERNS AND BLOOD PRESSURE VARIABILITY.
    J Hypertens. 2016;34 Suppl 2:e43.
    PubMed     Text format     Abstract available


  253. SKULTETYOVA D, Filipova S
    [OP.4A.06] RELATIONSHIP BETWEEN CIRCADIAN PATTERNS OF BLOOD PRESSURE AND CAROTID ARTERY STIFFNESS AND WAVE INTENSITY IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e41-2.
    PubMed     Text format     Abstract available


  254. CHI C, Zhang Y, Yu S, Argyris A, et al
    [OP.4A.04] ASSOCIATION OF CARDIAC STRUCTURE AND FUNCTION WITH CENTRAL AND BRACHIAL BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: THE SAFAR STUDY.
    J Hypertens. 2016;34 Suppl 2:e41.
    PubMed     Text format     Abstract available


  255. SALADINI F, Mos L, Fania C, Benetti E, et al
    [OP.4A.02] SHORT TERM BLOOD PRESSURE VARIABILTY AS PREDICTOR OF FUTURE EVENTS IN YOUNG STAGE I HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 2:e40.
    PubMed     Text format     Abstract available


  256. RAFAEL C, Khalek WA, Kouranti I, Clauser E, et al
    [OP.LB01.10] THE SKIPPING OF EXON 9 IN CULLIN-3 CAUSES A SEVERE FORM OF FAMILIAL HYPERKALEMIC HYPERTENSION IN MICE.
    J Hypertens. 2016;34 Suppl 2:e38-9.
    PubMed     Text format     Abstract available


  257. POULTER NR, Anjum A, Cross M, Falaschetti E, et al
    [OP.LB01.07] A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING (ABPM) LEVELS: A RANDOMISED CROSS-OVER TRIAL.
    J Hypertens. 2016;34 Suppl 2:e37-8.
    PubMed     Text format     Abstract available


  258. MALEK F, Vondrakova D, Dvorak J, Sedlackova L, et al
    [OP.3D.07] CORRELATION OF CERULOPLASMIN WITH BIOMARKERS OF CARDIAC REMODELLING AND MYOFIBROSIS: NT-PROBNP, SST2, GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e34-5.
    PubMed     Text format     Abstract available


  259. CANIFFI C, Gomez M, Alcober L, Prentky E, et al
    [OP.3D.05] HYPERTENSION AND VASCULAR INJURY: CHRONIC TREATMENT WITH C-TYPE NATRIURETIC PEPTIDE SHOWS BENEFICIAL EFFECTS ON THE LEVEL OF OXIDATIVE STRESS AND PRO-INFLAMMATORY CYTOKINES.
    J Hypertens. 2016;34 Suppl 2:e34.
    PubMed     Text format     Abstract available


  260. KASZUBA A, Konior A, Mikolajczyk T, Prejbisz A, et al
    [OP.3D.04] ACTIVATED CD4+ AND CD8+ T-CELL SUBPOPULATIONS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM AND TRUE RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e33-4.
    PubMed     Text format     Abstract available


  261. NOSALSKI R, Siedlinski M, Cat AN, Skiba D, et al
    [OP.3D.02] MICRORNA-214 IS INVOLVED IN THE REGULATION OF PERIVASCULAR FIBROSIS IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e33.
    PubMed     Text format     Abstract available


  262. MUELA HC, Costa-Hong V, Machado MF, Yassuda MS, et al
    [OP.3C.03] ARTERIAL STIFFNESS IS ASSOCIATED WITH LOWER PERFORMANCE ON THE COGNITIVE TESTS AT DIFFERENT DOMAINS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e31.
    PubMed     Text format     Abstract available


  263. FOULQUIER S, Namsolleck P, Recarti C, Van Hagen BT, et al
    [OP.3C.01] MICROGLIAL ACTIVATION IN HYPERTENSION-MEDIATED COGNITIVE IMPAIRMENT.
    J Hypertens. 2016;34 Suppl 2:e31.
    PubMed     Text format     Abstract available


  264. JARDIM T, Jardim L, Sousa A, Barroso W, et al
    [OP.3B.07] MULTIDISCIPLINARY TREATMENT FOR THE VERY ELDERLY HYPERTENSIVE PATIENT.
    J Hypertens. 2016;34 Suppl 2:e30.
    PubMed     Text format     Abstract available


  265. SILVA AP, Matos A, Ribeiro R, Gil A, et al
    [OP.3B.06] WILL BE CENTENARIANS, HYPERTENSIVE INDIVIDUALS? HOW IS THE BLOOD PRESSURE CONTROL OF CENTENARIANS IN PORTUGAL?
    J Hypertens. 2016;34 Suppl 2:e30.
    PubMed     Text format     Abstract available


  266. ANDREEVA G, Gorbunov V, Beloliperskaya V, Kukushkin S, et al
    [OP.1A.09] THE RELATIONSHIP BETWEEN THE AGGRESSION LEVEL OF PATIENTS WITH ARTERIAL HYPERTENSION AND THE ANTIHYPERTENSIVE DRUG EFFECTIVENESS.
    J Hypertens. 2016;34 Suppl 2:e3.
    PubMed     Text format     Abstract available


  267. GAZZOLA K, Cammenga M, Van Der Hoeven N, Van Montfrans G, et al
    [OP.1A.07] INCREMENTAL DIFFERENCES BETWEEN HOME AND AMBULATORY BLOOD PRESSURE AND THEIR RELATION TO ANXIETY AND HYPERTENSIVE ORGAN DAMAGE: EVIDENCE FOR AN 'AUTO-CUFF' RESPONSE?
    J Hypertens. 2016;34 Suppl 2:e3.
    PubMed     Text format     Abstract available


  268. ZHAO X, Yu J
    [OP.3A.07] DROSPIRENONE WITH ESTRADIOL FOR POSTMENOPAUSAL WOMEN WITH HYPERTENSION: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 2:e28.
    PubMed     Text format     Abstract available


  269. JEKELL A, Kalani M, Kahan T
    [OP.2D.07] THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN OR ACE-INHIBITION BY RAMIPRIL ON ENDOTHELIAL FUNCTION IN PRIMARY HYPERTENSION: THE DORA STUDY.
    J Hypertens. 2016;34 Suppl 2:e25.
    PubMed     Text format     Abstract available


  270. TRIANTAFYLLIDI H, Benas D, Vlachos S, Schoinas A, et al
    [OP.2D.06] DIFFERENCES IN ENDOTHELIAL GLYCOCALYX IN RECENTLY DIAGNOSED AND UNTREATED MIDDLE-AGED HYPERTENSIVE PATIENTS REGARDING INCREASED CARDIOVASCULAR RISK.
    J Hypertens. 2016;34 Suppl 2:e25.
    PubMed     Text format     Abstract available


  271. COTTONE S, Nardi E, Guarneri M, Guarino L, et al
    [OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e25.
    PubMed     Text format     Abstract available


  272. IONIN V, Zaslavskaya EL, Belyaeva OD, Soboleva AV, et al
    [OP.2C.06] NEW RISK FACTORS FOR ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTENSION AND OBESITY.
    J Hypertens. 2016;34 Suppl 2:e23.
    PubMed     Text format     Abstract available


  273. VARGA A, Tatar CM, Mitre A, Podoleanu C, et al
    [OP.2C: 05] ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS. A SINGLE PILOT ANTICOAGULATION RISK MANAGEMENT CENTER.
    J Hypertens. 2016;34 Suppl 2:e23.
    PubMed     Text format     Abstract available


  274. WANG Q, Chang P, Xu H, Bai F, et al
    [OP.2C.01] TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/P-AKT PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e22.
    PubMed     Text format     Abstract available


  275. CHI C, Yu S, Bai B, Wang K, et al
    [OP.1A.06] HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 2:e2.
    PubMed     Text format     Abstract available


  276. VRDOLJAK A, Ivkovic V, Karanovic S, Dika Z, et al
    [OP.2B.03] GLOMERULAR HYPERFILTRATION AS A RISK FACTOR FOR RENAL IMPAIRMENT AND HYPERTENSION IN APPARENTLY HEALTHY SUBJECTS.
    J Hypertens. 2016;34 Suppl 2:e19.
    PubMed     Text format     Abstract available


  277. MARKETOU M, Parthenakis F, Kontaraki J, Maragoudakis F, et al
    [OP.2B.02] COMPARATIVE MICRORNA PROFILING IN RELATION TO URINARY ALBUMIN EXCRETION IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e19.
    PubMed     Text format     Abstract available


  278. THOMAS-JEAN F, Pannier B, Hanon O, Czernichow S, et al
    [OP.2A.09] SYSTOLIC BLOOD PRESSURE VARIATION DURING 6 YEARS AND MORTALITY: THE AGE AMPLIFIES THE IMPACT OF A SPONTANEOUS INCREASE OR REDUCTION OF PRESSURE AMONG HYPERTENSIVE: IPC COHORT.
    J Hypertens. 2016;34 Suppl 2:e18.
    PubMed     Text format     Abstract available


  279. STERGIOU GS, Margetaki A, Boubouchairopoulou N, Mastrokostas A, et al
    [OP.2A.08] HYPERTENSION AND CARDIOVASCULAR DISEASE IN GREECE: INTERIM ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e17-8.
    PubMed     Text format     Abstract available


  280. DEBORDE T, Amar L, Bobrie G, Burgun A, et al
    [OP.2A.07] TRENDS IN PATIENTS ATTENDING A TERTIARY HYPERTENSION UNIT: PATIENTS' CHARACTERISTICS AND TREATMENT STRATEGIES STRONGLY EVOLVED OVER THE LAST 15 YEARS.
    J Hypertens. 2016;34 Suppl 2:e17.
    PubMed     Text format     Abstract available


  281. WALLENTIN F, Wettermark B, Kahan T
    [OP.2A.06] CURRENT DRUG TREATMENT OF HYPERTENSION IN SWEDEN IN RELATION TO GENDER, AGE, AND COMORBIDITY.
    J Hypertens. 2016;34 Suppl 2:e17.
    PubMed     Text format     Abstract available


  282. JUMAR A, Ott C, Kistner I, Friedrich S, et al
    [OP.1D.07] EARLY SIGNS OF END-ORGAN DAMAGE IN RETINAL ARTERIOLES IN TYPE 2 DIABETIC IN COMPARISON WITH HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e13.
    PubMed     Text format     Abstract available


  283. KARPANOU E, Vyssoulis G, Demerouti E, Grassos H, et al
    [OP.1D.06] SALT CONSUMPTION AND GLUCOSE METABOLISM IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e13.
    PubMed     Text format     Abstract available


  284. POLONIA J, Ferreira C, Castro P, Penas S, et al
    [OP.1D.03] NIGHTTIME BLOOD PRESSURE IS THE MAJOR DETERMINANT FACTOR OF BOTH MACROVASCULAR AND MICROVASCULAR LESIONS IN A COOHORT OF TYPE 2 DIABETIC AND NON-DIABETIC HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e12.
    PubMed     Text format     Abstract available


  285. NIBOUCHE N, Lanasri N, Chibane A, Zeraoulia F, et al
    [OP.1D.02] ORTHOSTATIC HYPERTENSION IN NORMOTENSIVE PATIENTS PREDICTS PERMANENT ARTERIAL HYPERTENSION IN TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2016;34 Suppl 2:e12.
    PubMed     Text format     Abstract available


  286. WIJKMAN M, Lanne T, Ostgren CJ, Nystrom FH, et al
    [OP.1D.01] DIASTOLIC ORTHOSTATIC HYPERTENSION PREDICTS A FAVORABLE CARDIOVASCULAR PROGNOSIS IN TYPE 2 DIABETES.
    J Hypertens. 2016;34 Suppl 2:e12.
    PubMed     Text format     Abstract available


  287. TSIOUFIS C, Kasiakogias A, Dimitriadis K, Kalos T, et al
    [OP.LB03.07] EFFECTS OF LERCANIDIPINE/ENALAPRIL COMPARED WITH AMLODIPINE/ENALAPRIL AND HYDROCHLOROTHIAZIDE/ENALAPRIL ON TARGET ORGAN DAMAGE AND SYMPATHETIC ACTIVITY IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e113.
    PubMed     Text format     Abstract available


  288. AGNOLETTI D, Lieber A, Valbusa F, Arcaro G, et al
    [OP.LB03.03] THE RELATIONSHIP BETWEEN DIASTOLIC FUNCTION AND CENTRAL HEMODYNAMICS IN DIABETIC HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e111-2.
    PubMed     Text format     Abstract available


  289. BOUTOUYRIE P, Elmula F, Rebora P, Talvik A, et al
    [OP.LB03.02] NON-INVASIVE HEMODYNAMIC MONITORING IN UNCONTROLLED HYPERTENSIVE PATIENTS: EFFECT ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE: THE BEAUTY STUDY.
    J Hypertens. 2016;34 Suppl 2:e111.
    PubMed     Text format     Abstract available


  290. BURNIER M, Chappuis A, Glatz N, Bochud M, et al
    [OP.8E.08] REGIONAL VARIATIONS IN THE ASSOCIATIONS OF DIETARY PATTERNS WITH BLOOD PRESSURE AND HYPERTENSION IN SWITZERLAND.
    J Hypertens. 2016;34 Suppl 2:e110.
    PubMed     Text format     Abstract available


  291. LESIUK C, Courand PY, Milon H, Defforges-Ranc A, et al
    [OP.8E.06] A SUFFICIENT PROTEIN INTAKE SHOULD BE ENCOURAGED IN HYPERTENSIVE PATIENTS WITHOUT CHRONIC KIDNEY DISEASE: A LONG-TERM OUTCOMES STUDY.
    J Hypertens. 2016;34 Suppl 2:e109.
    PubMed     Text format     Abstract available


  292. MUIESAN ML, Riviera M, Pintossi C, Bertacchini F, et al
    [OP.8D.06] OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e106-7.
    PubMed     Text format     Abstract available


  293. XU T, Sun JP, Lee AP, Yang Y, et al
    [OP.8D.05] LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e106.
    PubMed     Text format     Abstract available


  294. MARAIS L, Pernot M, Khettab H, Tanter M, et al
    [OP.8D.03] MEASUREMENT OF ARTERIAL STIFFNESS BY ULTRAFAST ECHO: COMPARISON WITH ECHOTRACKING IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e105-6.
    PubMed     Text format     Abstract available


  295. MARC Y, Hmazzou R, Flahault A, Llorens-Cortes C, et al
    [OP.8C.06] CENTRAL ANTIHYPERTENSIVE EFFECTS OF CHRONIC TREATMENT WITH RB150/QGC001, AN ORALLY ACTIVE AMINOPEPTIDASE A INHIBITOR PRODRUG IN DOCA-SALT HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e103.
    PubMed     Text format     Abstract available


  296. KONG L, Ruan C, Ma Y, Gao P, et al
    [OP.8C.05] A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIORENAL CONSEQUENCE.
    J Hypertens. 2016;34 Suppl 2:e103.
    PubMed     Text format     Abstract available


  297. ASHLEY Z, Leader C, Sammut I, McDonald F, et al
    [OP.8C.04] THE FLOW DETECTION ROLE OF THE VASCULAR EPITHELIAL SODIUM CHANNEL (ENAC) IN AN EXPERIMENTAL MODEL OF HYPERTENSION: THE NOVEL TARGET FOR SPIRONOLACTONE THERAPY?
    J Hypertens. 2016;34 Suppl 2:e103.
    PubMed     Text format     Abstract available


  298. GRABOWSKI K, Herlan L, Eisenreich A, Schulz A, et al
    [OP.8C.01] A NOVEL CANDIDATE GENE IDENTIFIED IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS HAS A MAJOR IMPACT ON ADVERSE LEFT VENTRICULAR REMODELING IN SALT-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e102.
    PubMed     Text format     Abstract available


  299. NOWAK MM, Komand A, Ostrowka D, Jancewicz M, et al
    [OP.8B.07] UTILITY OF SLEEP-POLYGRAPHIC STUDIES IN TERTIARY-CARE HYPERTENSION OUT-PATIENT CLINIC.
    J Hypertens. 2016;34 Suppl 2:e101.
    PubMed     Text format     Abstract available


  300. BUGAEV T, Ageeva NV, Dobrovolskiy AB, Litvin AY, et al
    [OP.8B.05] COAGULATION SYSTEM ACTIVITY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA SYNDROME AND ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e101.
    PubMed     Text format     Abstract available


  301. BRUNO R, Ghiadoni L, Cervia S, Biancheri R, et al
    [OP.8B.04] GENDER DIFFERENCES IN THE IMPACT OF DYSFUNCTIONAL COPING IN A HYPERTENSIVE POPULATION.
    J Hypertens. 2016;34 Suppl 2:e101.
    PubMed     Text format     Abstract available


  302. LOMBARDI C, Parati G, Soranna D, Zambon A, et al
    [OP.8B.01] PERIODIC LIMB MOVEMENT DURING SLEEP, SLEEP RELATED BREATHING DISORDERS AND HYPERTENSION IN THE ESADA COHORT.
    J Hypertens. 2016;34 Suppl 2:e100.
    PubMed     Text format     Abstract available


  303. YANNOUTSOS A, Ahouah M, Dreyfuss Tubiana C, Topouchian J, et al
    [OP.1C.08] HEMODYNAMIC PARAMETERS IN HYPERTENSIVE DIABETIC PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e10.
    PubMed     Text format     Abstract available


  304. RAYNER B
    SSA 05-4 DIFFERENCES IN MANAGEMENT OF HYPERTENSION BETWEEN ETHNIC GROUPS.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  305. SCHUTTE A
    SSA 05-3 THE PROGRESSION OF HYPERTENSION IN AFRICA.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  306. KADIRI S
    SSA 05-2 HYPERTENSION AND KIDNEY COMPLICATION IN AFRICA.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  307. DAMASCENO A
    SSA 05-1 HYPERTENSION, STEADY BUT CONTINUING CHANGES IN DEVELOPING COUNTRIES.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  308. WANG W, Ma L, Sui H, Liu L, et al
    OS 12-05 THE EFFECT OF INTENSIVE LIFESTYLE INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION, SUB-ANALYSIS FROM CHIEF.
    J Hypertens. 2016;34 Suppl 1:e77.
    PubMed     Text format     Abstract available


  309. KARIO K, Hoshide S
    OS 12-01 ARB AND CCB LONGEST COMBINATION TREATMENT ON AMBULATORY AND HOME BP IN HYPERTENSION WITH ATRIAL FIBRILLATION - MULTICENTER STUDY ON TIME OF DOSING (ACROBAT).
    J Hypertens. 2016;34 Suppl 1:e76.
    PubMed     Text format     Abstract available


  310. SOKOLOVIC S, Mehmedagic S
    OS 11-06 The effect of vagus nerve stimulation on arterial hypertension using active implantable device.
    J Hypertens. 2016;34 Suppl 1:e75.
    PubMed     Text format     Abstract available


  311. WALAS D, Von Roloff E, Paton J
    OS 11-05 Superior cervical ganglionectomy (SCGx) reduces sympathetic innervation of vertebrobasilar arteries but does not affect cerebrovascular remodelling in the adult spontaneously hypertensive rat (SHR).
    J Hypertens. 2016;34 Suppl 1:e75.
    PubMed     Text format     Abstract available


  312. NISHIYAMA A, Hitomi H, Nakano D, Fujisawa Y, et al
    OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats.
    J Hypertens. 2016;34 Suppl 1:e74-5.
    PubMed     Text format     Abstract available


  313. KIM MN, Kim YB, Park SM, Kim YI, et al
    OS 11-02 Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats.
    J Hypertens. 2016;34 Suppl 1:e74.
    PubMed     Text format     Abstract available


  314. WAINFORD R, Carmichael C, Walsh K
    OS 11-01 Afferent renal nerve modulation of sodium homeostasis and blood pressure: A sodium sensitive PVN Galphai2 protein dependent mechanism countering the development of salt-sensitive hypertension?
    J Hypertens. 2016;34 Suppl 1:e74.
    PubMed     Text format     Abstract available


  315. PAULETTO P, Puato M, Rattazzi M, Buso R, et al
    OS 10-06 THE IMPACT OF WELL CONTROLLED BLOOD PRESSURE LEVELS ON ARTERIAL PROPERTIES IN ESSENTIAL HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e73.
    PubMed     Text format     Abstract available


  316. LIU Z, Zhao Y, Dong Y, Lu B, et al
    OS 10-02 EFFECTS OF HELICOBACTER PYLORI INFECTION ON ATHEROSCLEROSIS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS IN AGED POPULATION.
    J Hypertens. 2016;34 Suppl 1:e72.
    PubMed     Text format     Abstract available


  317. BURSZTYN M, Ben-Dov IZ
    OS 09-03 EXTREME DIPPING IS NOT ASSOCIATED WITH INCREASED MORTALITY IN BOTH TREATED AND UNTREATED HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e70.
    PubMed     Text format     Abstract available


  318. GUO QH, Kang YY, Song J, Chen Q, et al
    OS 09-02 PREVALENCE AND DETERMINANTS OF EXAGGERATED MORNING SURGE AND MORNING HYPERTENSION IN CHINESE: THE CHINA AMBULATORY AND HOME BLOOD PRESSURE REGISTRY (ABPR).
    J Hypertens. 2016;34 Suppl 1:e70.
    PubMed     Text format     Abstract available


  319. FAN H, Yan Y, Dong H, Mi J, et al
    OS 09-01 PREVALENCE OF HYPERTENSION AFTER THREE SEPARATE OCCASIONS AMONG CHINESE CHILDREN: A NATIONAL REPRESENTATIVE CROSS-SECTION SURVEY.
    J Hypertens. 2016;34 Suppl 1:e70.
    PubMed     Text format     Abstract available


  320. QUINTANA FS
    SSA 04-4 CURRENT STATUS IN MANAGEMENT OF HYPERTENSION IN LATIN AMERICA.
    J Hypertens. 2016;34 Suppl 1:e7-8.
    PubMed     Text format     Abstract available


  321. HUANG F, Huang Q, Lin F, Zhu P, et al
    OS 08-02 APELIN AND APLN SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINED HYPERTENSION AND CENTRAL RETINAL ARTERY STENOSIS IN A CHINESE POPULATION.
    J Hypertens. 2016;34 Suppl 1:e68.
    PubMed     Text format     Abstract available


  322. RAZA ST, Abbas S, Mahdi F
    OS 08-01 ASSOCIATION OF ACE, FABP2, PPARG2, GST, FTO AND CYP46A1 GENES POLYMORPHISM WITH ESSENTIAL HYPERTENSION AMONG NORTH INDIAN POPULATION.
    J Hypertens. 2016;34 Suppl 1:e68.
    PubMed     Text format     Abstract available


  323. YI JE, Pyun WB, Lee Y, Park J, et al
    OS 07-05 DETERMINANTS OF MORNING BLOOD PRESSURE SURGE IN NORMOTENSIVE SUBJECTS AND UNTREATED HYPERTENSIVE PATIENTS: THE KOREAN AMBULATORY BLOOD PRESSURE MULTICENTER OBSERVATIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1:e66.
    PubMed     Text format     Abstract available


  324. MA R, Wang Q, Li N, Zhao Y, et al
    OS 07-04 HOME BLOOD PRESSURE MONITORING IMPROVED SAFETY IN PATIENTS WITH SEVERE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e66.
    PubMed     Text format     Abstract available


  325. KARIO K, Bhatt D, Brar S, Bakris G, et al
    OS 07-02 DIFFERENCES IN CIRCADIAN BLOOD PRESSURE VARIABILITY PATTERNS BETWEEN JAPANESE AND AMERICAN TREATMENT-RESISTANT HYPERTENSIVE POPULATIONS.
    J Hypertens. 2016;34 Suppl 1:e65.
    PubMed     Text format     Abstract available


  326. ZHANG DY, Cheng YB, Guo QH, Xu TY, et al
    OS 07-01 SUBTYPES OF MASKED HYPERTENSION AND THEIR ASSOCIATIONS WITH TARGET ORGAN DAMAGE IN UNTREATED CHINESE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e65.
    PubMed     Text format     Abstract available


  327. VAN BALLEGOOIJEN A, Van Schoor N, Brouwer I, Visser M, et al
    OS 06-09 THE SYNERGISTIC ASSOCIATION BETWEEN VITAMIN D AND VITAMIN K WITH INCIDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e64.
    PubMed     Text format     Abstract available


  328. BURSZTYN M, Hammerman-Rozenberg A, Jacobs J, Stessman J, et al
    OS 06-06 PREVALENCE AND CONSEQUENCE OF ORTHOSTATIC HYPERTENSION IN COMMUNITY DWELLING 85, AND 90 YEAR OLDS.
    J Hypertens. 2016;34 Suppl 1:e63.
    PubMed     Text format     Abstract available


  329. MORE A, Kadam R, Mohite K, Mittal C, et al
    OS 06-05 HEALTHCARE STRUCTURE IN RURAL INDIA AND ITS IMPLICATIONS ON DIAGNOSIS AND MANAGEMENT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e63.
    PubMed     Text format     Abstract available


  330. LIU L, Dow J, Simon B, Eisen H, et al
    OS 06-02 MULTIPLE ANTIHYPERTENSIVE MEDICATION USE, RESISTANT HYPERTENSION AND OUTCOMES IN THE UNITED STATES: FINDINGS FROM NHANES 1988 TO 2012.
    J Hypertens. 2016;34 Suppl 1:e62.
    PubMed     Text format     Abstract available


  331. MAMUN A
    OS 06-01 DEVELOPMENTAL STAGES OF HYPERTENSION BETWEEN MALES AND FEMALES- ARE THERE DIFFERENT MECHANISMS?
    J Hypertens. 2016;34 Suppl 1:e62.
    PubMed     Text format     Abstract available


  332. KIM S, Wang G, Lobaton G, Li E, et al
    OS 05-10 THE MICROBIAL METABOLITE, BUTYRATE ATTENUATES ANGIOTENSIN II-INDUCED HYPERTENSION AND DYSBIOSIS.
    J Hypertens. 2016;34 Suppl 1:e60-1.
    PubMed     Text format     Abstract available


  333. MAYOROV D, Kasparov S, Paton J
    OS 05-09 REDUCED VASODILATOR EFFICIENCY OF ADENOSINE IN THE BRAINSTEM OF YOUNG SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e60.
    PubMed     Text format     Abstract available


  334. NEZU M, Souma T, Yu L, Sekine H, et al
    OS 05-05 Nrf2 DEFICIENCY ALLEVIATES PERINATAL COMPLICATIONS IN PREGNANCY-ASSOCIATED HYPERTENSION MICE VIA ENHANCING PLACENTAL ANGIOGENESIS.
    J Hypertens. 2016;34 Suppl 1:e59.
    PubMed     Text format     Abstract available


  335. ABASSI Z, Leor J, Landa N, Younis F, et al
    OS 05-04 EMPAGLIFLOZIN EXERTS CARDIO- AND NEPHRO-PROTECTIVE EFFECTS IN COHEN-ROSENTHAL DIABETIC HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e58-9.
    PubMed     Text format     Abstract available


  336. ZICHA J, Behuliak M, Vaneckova I
    OS 05-03 DECREASED RHO-KINASE-BASED CALCIUM SENSITIZATION IN HYPERTENSIVE REN-2 TRANSGENIC RATS (TGR).
    J Hypertens. 2016;34 Suppl 1:e58.
    PubMed     Text format     Abstract available


  337. ZHU W, Li J, Sun X, Hua Q, et al
    OS 05-02 ASSOCIATION OF G-PROTEIN BETA3 SUBUNIT GENE C825T POLYMORPHISM WITH CARDIAC AND CEREBROVASCULAR EVENTS IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e58.
    PubMed     Text format     Abstract available


  338. KOKKINOS P, Puneet N, Apostolos T, Michael D, et al
    OS 04-09 CARDIORESPIRATORY FITNESS AND RISK FOR DEVELOPING HEART FAILURE IN HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e57.
    PubMed     Text format     Abstract available


  339. SINNOTT SJ, Root A, Mathur R, Mansfield K, et al
    OS 04-07 THE COMPARATIVE EFFECTIVENESS OF 4TH LINE ANTI-HYPERTENSIVE AGENTS IN PATIENTS WITH RESISTANT HYPERTENSION: A META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1:e56-7.
    PubMed     Text format     Abstract available


  340. MEENA J, Raghav P, Rustagi N
    LBOS 03-06 ANTI HYPERTENSIVE TREATMENT COMPLIANCE AND ADVERSE EFFECT PROFILE AMONG HYPERTENSION CLINIC ATTENDEES IN JODHPUR, INDIA.
    J Hypertens. 2016;34 Suppl 1:e552.
    PubMed     Text format     Abstract available


  341. KOHLI C, Gupta K
    LBOS 03-03 ECONOMIC IMPACT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e551-2.
    PubMed     Text format     Abstract available


  342. KARAMAT F, Diemer F, Baldew S, Oehlers G, et al
    LBOS 03-02 PREHYPERTENSION AND HYPERTENSION IN URBAN SURINAME: THE HELISUR STUDY.
    J Hypertens. 2016;34 Suppl 1:e551.
    PubMed     Text format     Abstract available


  343. YUSUFALI A, Khatib R, Islam S, AlHabib K, et al
    LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY.
    J Hypertens. 2016;34 Suppl 1:e551.
    PubMed     Text format     Abstract available


  344. DEY SK, Prabhakar P, Saini M, Joseph T, et al
    LBOS 02-05 INHIBITORS OF DOPAMINE-beta-HYDROXYLASE OBTAINED BY STRUCTURE BASED METHODS EXHIBITED ANTI-HYPERTENSIVE EFFECT IN L-NAME INDUCED HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e550.
    PubMed     Text format     Abstract available


  345. CRIPPA G, Zabzuni D, Bravi E, Rossi F, et al
    OS 04-04 ANTIHYPERTENSIVE EFFECT OF MILK-DERIVATIVE TRIPEPTIDES. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFECTS OF GRANA PADANO CHEESE DOP IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e55-6.
    PubMed     Text format     Abstract available


  346. LIU D
    LBOS 02-02 TELMISARTAN REDUCING MONOCYTE MITOCHONDRIA RESPIRATORY FUNCTION IS ASSOCIATED WITH INHIBITION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL CANONICAL TYPE 3 CHANNELS IN HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e549.
    PubMed     Text format     Abstract available


  347. TAO J
    LBOS 02-01 HYPERTENSION, ALDOSTERONE AND EPC-MEDIATED ENDOTHALIAL INJURY REPAIR.
    J Hypertens. 2016;34 Suppl 1:e549.
    PubMed     Text format     Abstract available


  348. VILLEVALDE S, Kobalava Z
    LBOS 01-06 INTEGRATED APPROACH IMPROVED BLOOD PRESSURE CONTROL IN NON ADHERENT MOTIVATED HYPERTENSIVE PATIENTS: PRISMA STUDY.
    J Hypertens. 2016;34 Suppl 1:e548.
    PubMed     Text format     Abstract available


  349. CHO EJ, Lee HY, Sung KC, Park S, et al
    LBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e548.
    PubMed     Text format     Abstract available


  350. SEVER P, Gupta A, Thompson D, Whitehouse A, et al
    LBOS 01-04 THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT).
    J Hypertens. 2016;34 Suppl 1:e547-8.
    PubMed     Text format     Abstract available


  351. VILLEVALDE S, Kovbalava Z
    LBOS 01-03 MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e547.
    PubMed     Text format     Abstract available


  352. MARCUS Y, Haran A, Shefer G, Stern N, et al
    LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e547.
    PubMed     Text format     Abstract available


  353. POULTER N, Anjum A, Cross M, Falaschetti E, et al
    LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS: A RANDOMISED CROSS-OVER TRIAL (HARMONY).
    J Hypertens. 2016;34 Suppl 1:e547.
    PubMed     Text format     Abstract available


  354. MUTHUSAMY VV
    BR 08-3 MANAGEMENT OF DYSLIPIDEMIA IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e545.
    PubMed     Text format     Abstract available


  355. PARK J
    BR 08-2 CARDIOVASCULAR RISK ASSESSMENT IN HYPERTENSIVES WITH CKD.
    J Hypertens. 2016;34 Suppl 1:e544-5.
    PubMed     Text format     Abstract available


  356. ZHU Z
    BR 08-1 HIGH SODIUM INTAKE REDUCTION IN DIABETES WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e544.
    PubMed     Text format     Abstract available


  357. PARK JB
    ME 04-2 AORTIC PWV FOR RISK STRATIFICATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e541.
    PubMed     Text format     Abstract available


  358. ZHANG P, Sun N, Wang H, Sun L, et al
    OS 03-08 EFFICACY OF TELMISARTAN 40 MG (T40) AND HYDROCHLOROTHIAZIDE 25 MG (H25) MONOTHERAPY IN HIGH SODIUM INTAKE PATIENTS WITH MILD TO MODERATE HYPERTENSION (THAT STUDY): A MULTICENTER RANDOMIZED DOUBLE-BLINDED PARALLEL CONTROLLED TRIAL.
    J Hypertens. 2016;34 Suppl 1:e54.
    PubMed     Text format     Abstract available


  359. KIM SH
    HW 03-2 EFFECT OF CPAP ON THE TREATMENT OF RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e538.
    PubMed     Text format     Abstract available


  360. KIM BK
    HW 03-1 RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION UNDER OPTIMAL DRUG THERAPY.
    J Hypertens. 2016;34 Suppl 1:e538.
    PubMed     Text format     Abstract available


  361. RAIZADA M
    SY 17-4 NEURO-IMMUNE COMMUNICATION IN HYPERTENSION: A NEW THERAPEUTIC ANGLE?
    J Hypertens. 2016;34 Suppl 1:e535.
    PubMed     Text format     Abstract available


  362. HARRISON D
    SY 17-2 INFLAMMATION, IMMUNITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e535.
    PubMed     Text format     Abstract available


  363. VAN BALLEGOOIJEN A
    SY 16-4 VITAMIN D WITH OR WITHOUT CALCIUM SUPPLEMENTATION IN RELATION TO HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e534.
    PubMed     Text format     Abstract available


  364. TURANA Y
    SSA 03-4 THE BRAIN SCREENING IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e5.
    PubMed     Text format     Abstract available


  365. OH VM
    SSA 03-3 DIETARY SALT INTAKE AND HYPERTENSION IN SINGAPORE.
    J Hypertens. 2016;34 Suppl 1:e5.
    PubMed     Text format     Abstract available


  366. WANG Q, Euy-Myoung J, Liu H, Gu L, et al
    OS 02-04 ASTRAGALOSIDE IV IMPROVES LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSIVE MICE BY INCREASING THE PHOSPHORYLATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE.
    J Hypertens. 2016;34 Suppl 1:e48-9.
    PubMed     Text format     Abstract available


  367. HARVEY AP, Montezano A, Wong KC, Hood KY, et al
    OS 02-01 ROLE OF ALDOSTERONE AND NADPH OXIDASE 1 IN HYPERTENSION-ASSOCIATED VASCULAR AGING.
    J Hypertens. 2016;34 Suppl 1:e48.
    PubMed     Text format     Abstract available


  368. PARK SH, Park CG, Na JO, Choi CU, et al
    OS 01-08 IMPACT OF HYPERTENSION TREATMENT ON IMMUNOSENESCENCE PARAMETERS.
    J Hypertens. 2016;34 Suppl 1:e46.
    PubMed     Text format     Abstract available


  369. SUNG KC
    OS 01-06 LOW GRADE ALBUMINURIA IS A PREDICTOR OF INCIDENT HYPERTENSION AND CARDIOVASCULAR MORTALITY BUT IS NOT A PREDICTOR OF INCIDENT TYPE 2 DIABETES.
    J Hypertens. 2016;34 Suppl 1:e45-6.
    PubMed     Text format     Abstract available


  370. KWON A, Chung WB, Kim TH, Suh SM, et al
    OS 01-05 HIGH ALDOSTERONE-RENIN RATIO (ARR) IS ASSOCIATED WITH THE DEVELOPMENT OF ESSENTIAL HYPERTENSION FROM WHITE COAT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e45.
    PubMed     Text format     Abstract available


  371. SONG SK, Lee SR, Jung LY, Kim YS, et al
    OS 01-04 WHOLE BLOOD VISCOSITY WAS ELEVATED IN PATIENTS WITH BOTH HYPERTENSION AND ACUTE CORONARY SYNDROME.
    J Hypertens. 2016;34 Suppl 1:e45.
    PubMed     Text format     Abstract available


  372. KIM DO Y, Choi SW, Han SW, Youn JC, et al
    OS 01-03 NEUTROPHIL TO LYMPHOCYTE RATIO IS CLOSELY RELATED WITH BLOOD PRESSURE LEVEL IN HYPERTENSIVE INDIVIDUALS WITHOUT CARDIOVASCULAR DISEASES; DATA FROM THE KOREAN REGISTRY OF TARGET ORGAN DAMAGES IN HYPERTENSION (KorHR).
    J Hypertens. 2016;34 Suppl 1:e44-5.
    PubMed     Text format     Abstract available


  373. MALYSZKO J, Musialowska D, Zbroch E, Koc-Zorawska E, et al
    OS 01-02 ENDOCAN LEVEL IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e44.
    PubMed     Text format     Abstract available


  374. WANG Y, Zhang J, Qian Y, Tang X, et al
    OS 01-01 ASSOCIATION OF Lp-PLA2 MASS AND AYSMPTOMATIC INTRACRANIAL AND EXTRACRANIAL ARTERIAL STENOSIS IN HYPERTENSION PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e44.
    PubMed     Text format     Abstract available


  375. WALAS D, Nowicki-Osuch K, Alibhai D, Paton J, et al
    ISH NIA OS-06 PUTATIVE MECHANISMS FOR CEREBROVASCULAR REMODELLING IN THE SPONTANEOUSLY HYPERTENSIVE RAT (SHR) USING TRANSCRIPTOMICS.
    J Hypertens. 2016;34 Suppl 1:e43.
    PubMed     Text format     Abstract available


  376. PIJACKA W, McBryde F, Ford AP, Paton JF, et al
    ISH NIA OS-04 P2X3 RECEPTOR ACTIVITY IN THE CAROTID BODY (CB) OF SPONTANEOUSLY HYPERTENSIVE (SH) RATS CONTRIBUTES TO INCREASED CHEMOREFLEX HYPERSENSITIVITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e42-3.
    PubMed     Text format     Abstract available


  377. TIMASHEVA Y, Nasibullin T, Imaeva E, Mirsaeva G, et al
    ISH NIA OS-03 GENETIC DETERMINANTS OF ESSENTIAL HYPERTENSION IN THE POPULATION OF TATARS FROM RUSSIA.
    J Hypertens. 2016;34 Suppl 1:e42.
    PubMed     Text format     Abstract available


  378. AZEGAMI T, Yuki Y, Hayashi K, Nakamura M, et al
    ISH NIA OS-02 ATTENUATION OF HYPERTENSION BY LESS-INVASIVE INTRANASAL VACCINATION AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e42.
    PubMed     Text format     Abstract available


  379. XU T, Sun J, Lee AP, Yang Y, et al
    OS 37-09 LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e407.
    PubMed     Text format     Abstract available


  380. KIM D, Shim CY, Hong GR, Cho IJ, et al
    OS 37-08 ASSOCIATION OF CENTRAL HEMODYNAMICS AND NEUROHORMONAL FACTORS TO MECHANICAL ADAPTATION OF LEFT VENTRICLE IN HYPERTENSION: A STUDY WITH TWO DIMENSIONAL LAYER SPECIFIC SPECKLE TRACKING STRAIN IMAGING.
    J Hypertens. 2016;34 Suppl 1:e407.
    PubMed     Text format     Abstract available


  381. LIM HM, Chia YC, Ching SM
    OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS.
    J Hypertens. 2016;34 Suppl 1:e406.
    PubMed     Text format     Abstract available


  382. CHO KI, Cho EA, Heo JH, Kim HS, et al
    OS 37-04 EFFECTS OF WHITE COAT HYPERTENSION ON HEART RATE RECOVERY AND BLOOD PRESSURE RESPONSE DURING EXERCISE TESTING.
    J Hypertens. 2016;34 Suppl 1:e406.
    PubMed     Text format     Abstract available


  383. LEE JY, Sung KC
    OS 37-03 IMPACT OF CHANGE IN EXERCISE DOSE ON RISK OF NEWLY DEVELOPED HYPERTENSION AND DIABETES MELLITUS IN KOREAN MEN.
    J Hypertens. 2016;34 Suppl 1:e405-6.
    PubMed     Text format     Abstract available


  384. AMUSA G, Awokola B, Isiguzo G, Onuh J, et al
    OS 37-02 HYPERTENSION IN HIV-INFECTED ADULTS IN NORTH-CENTRAL NIGERIA: PREVALENCE, ASSOCIATED RISK FACTORS AND ASSESSMENT OF RISK USING THE FRAMINGHAM RISK SCORE.
    J Hypertens. 2016;34 Suppl 1:e405.
    PubMed     Text format     Abstract available


  385. KONG L, Ruan C, Gao P
    OS 36-08 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIOVASCULAR INJURY.
    J Hypertens. 2016;34 Suppl 1:e404.
    PubMed     Text format     Abstract available


  386. ZHONG JC, Zhang ZZ, Xu R, Chen LJ, et al
    OS 36-07 TREATMENT WITH APELIN-13 PREVENTS PRESSURE OVERLOAD-INDUCED AORTIC ADVENTITIAL REMODELING AND FIBROSIS IN HYPERTENSIVE RATS WITH TAC.
    J Hypertens. 2016;34 Suppl 1:e403-4.
    PubMed     Text format     Abstract available


  387. ZUO C
    OS 36-06 OSTEOGLYCIN INHIBITS HYPERTENSIVE CARDIAC FIBROSIS THOUGH SUPPRESSION OF EGFR SIGNALING.
    J Hypertens. 2016;34 Suppl 1:e403.
    PubMed     Text format     Abstract available


  388. WANG Q, Chang P, Xu H, Bai F, et al
    OS 36-05 TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/p-Akt PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e403.
    PubMed     Text format     Abstract available


  389. WANG Q, Xie A, Xu H, Yu J, et al
    OS 36-02 ASTRAGALOSIDE IV AMELIORATED MITOCHONDRIAL OXIDATIVE STRESS IN HYPERTENSIVE MICE WITH CARDIOMYOPATHY BY REGULATING MITOCHONDRIAL Ca2+ FLUX.
    J Hypertens. 2016;34 Suppl 1:e402.
    PubMed     Text format     Abstract available


  390. MAIOLINO G, Flego A, Rossi GP
    OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY.
    J Hypertens. 2016;34 Suppl 1:e401.
    PubMed     Text format     Abstract available


  391. XU J, Ge Q, Zhang J, Zhu L, et al
    OS 35-06 COMPARISON OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e401.
    PubMed     Text format     Abstract available


  392. POGLITSCH M, Ahmed AH, Resl M, Stoller A, et al
    OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e400.
    PubMed     Text format     Abstract available


  393. RIPP T, Mordobin V, Ripp E, Semke G, et al
    ISH ADA-05 THE NEW TECHNOLOGY AND CLASSIFICATION FOR THE ARTERIES REACTIVITY IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e40.
    PubMed     Text format     Abstract available


  394. CHIA YC
    SSA 03-2 PREVALENCE AND PREDICTORS OF RESISTANT HYPERTENSION IN SOUTHEAST ASIA.
    J Hypertens. 2016;34 Suppl 1:e4-5.
    PubMed     Text format     Abstract available


  395. CASTILLO R
    SSA 03-1 PREVALENCE AND MANAGEMENT OF HYPERTENSION IN SOUTHEAST ASIA.
    J Hypertens. 2016;34 Suppl 1:e4.
    PubMed     Text format     Abstract available


  396. RYUNO H, Kamide K, Gondo Y, Kabayama M, et al
    OS 34-01 ASSOCIATION OF COMBINATION OF HYPERTENSION AND DIABETES WITH COGNITIVE FUNCTION AMONG THE 70-YEARS-OLD JAPANESE GENERAL POPULATION FROM LONGITUDINAL OBSERVATION IN THE SONIC STUDY.
    J Hypertens. 2016;34 Suppl 1:e396.
    PubMed     Text format     Abstract available


  397. WANG H, Chen H
    OS 33-09 ASSOCIATION OF CLOCK GENE POLYMORPHISM WITH INSULIN RESISTANCE IN HYPERTENSION: A CASE-CONTROL STUDY.
    J Hypertens. 2016;34 Suppl 1:e395.
    PubMed     Text format     Abstract available


  398. CAI A, Wang L, Zhou Y, Chen J, et al
    OS 33-08 OBSTRUCTIVE SLEEP APNEA PROMOTES CARDIOVASCULAR RISK IN HYPERTENSIVE POPULATIONS: A CROSS-SECTIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1:e395.
    PubMed     Text format     Abstract available


  399. TANAKA M, Nishimura T, Sekioka R, Kawai T, et al
    OS 33-07 LOW SERUM ALBUMIN CONCENTRATION IN HYPERTENSIVE PATIENTS COMPLICATED BY TYPE 2 DIABETES IS ASSOCIATED WITH MICROVASCULAR COMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e394-5.
    PubMed     Text format     Abstract available


  400. OGOLA E
    OS 33-05 HIGH PREVALENCE AND POOR CONTROL OF HYPERTENSION AND ASSOCIATED CARDIOVASCULAR RISK FACORS IN DIABETIC PATIENTS IN A RURAL HOSPITAL IN KENYA.
    J Hypertens. 2016;34 Suppl 1:e394.
    PubMed     Text format     Abstract available


  401. OPARIL S, Calhoun DA, Ghazi L, Dudenbostel T, et al
    OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX.
    J Hypertens. 2016;34 Suppl 1:e393.
    PubMed     Text format     Abstract available


  402. PENG L, Xia K, Zhao Z, Li D, et al
    OS 32-09 THE BENEFICIAL EFFECT OF LOSARTAN ON PLATELET AGGREGATION RESULTS FROM THE REDUCTION OF ENDOGENOUS ASYMMETRIC DIMETHYL ARGININE IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e391-2.
    PubMed     Text format     Abstract available


  403. YANG Z, Ruixin M, Jing Y
    OS 32-02 EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON VAGINA AND CARDIAC EXPRESSION OF RAAS COMPONENTS IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e390.
    PubMed     Text format     Abstract available


  404. JHEE JH, Yoo TH, Jung SY, Kee YK, et al
    ISH ADA-03 ADEQUATELY CONTROLLED SYSTOLIC BLOOD PRESSURE IS SIGNIFICANTLY ASSOCIATED WITH BETTER SURVIVAL RATE, IRRESPECTIVE OF NUMBER OF ANTIHYPERTENSIVE AGENTS IN PREVALENT DIALYSIS PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e39-40.
    PubMed     Text format     Abstract available


  405. CHEN X, Wang S, Li J, Zhou X, et al
    OS 31-06 COMPARISON BETWEEN THE EFFECTS OF HYDROCHLOROTHIAZIDE AND INDAPAMIDE ON THE KIDNEY IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH LOSARTAN.
    J Hypertens. 2016;34 Suppl 1:e389.
    PubMed     Text format     Abstract available


  406. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 31-04 COMPARISON OF CALCIUM CHANNEL BLOCKERS VERSUS CALCIUM CHANNEL BLOCKERS WITH RENIN ANGIOTENSIN SYSTEM BLOCKERS ON THE DEVELOPMENT OF NEW-ONSET DIABETES MELLITUS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e388-9.
    PubMed     Text format     Abstract available


  407. GIULIETTI F, Spannella F, Borioni E, Lombardi FE, et al
    OS 31-03 CLINICAL EFFECTIVENESS OF ANTI-HYPERTENSIVE THERAPY WITH ACEI OR ARB ASSESSED BY PLASMA RENIN ACTIVITY/PLASMA ALDOSTERONE CONCENTRATION RATIO.
    J Hypertens. 2016;34 Suppl 1:e388.
    PubMed     Text format     Abstract available


  408. ZENG W, Chu T, Hu M, Kong A, et al
    OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e388.
    PubMed     Text format     Abstract available


  409. KIM CH
    APSH PRE-1 WHAT CAN BE IMPROVED IN THE MANAGEMENT OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1:e387.
    PubMed     Text format     Abstract available


  410. KANG YY, Li Y, Huang QF, Song J, et al
    APSH YI-05 CIGARETTE SMOKING AND MASKED HYPERTENSION IN CHINESE MEN.
    J Hypertens. 2016;34 Suppl 1:e386.
    PubMed     Text format     Abstract available


  411. LEE CJ, Oh J, Lee SH, Kang SM, et al
    APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e385.
    PubMed     Text format     Abstract available


  412. TOUYZ RM
    ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e384.
    PubMed     Text format     Abstract available


  413. SAFAR ME
    ISH PRE-1 REDUCTION OF CARDIOVASCULAR MORTALITY IN HYPERTENSIVES WITH COMORBIDITIES: BEYOND BLOOD PRESSURE LOWERING - THE ROLE OF ARTERIAL AGING.
    J Hypertens. 2016;34 Suppl 1:e384.
    PubMed     Text format     Abstract available


  414. POGLITSCH M
    JS ISH-ECCR-4 THE PLASMA ALDOSTERONE / ANGIOTENSIN II RATIO FOR THE SCREENING OF SECONDARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e382-3.
    PubMed     Text format     Abstract available


  415. ROSSI GP
    JS ISH-ECCR-3 A NOVEL ALGORITHM FOR THE CASE DETECTION OF THE MOST COMMON FORM OF ENDOCRINE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e382.
    PubMed     Text format     Abstract available


  416. FUJITA T
    ME 03-1 ROLE OF ALDOSTERNE AND MINERALOCORTICOID RECEPTOR IN SALT-SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e379.
    PubMed     Text format     Abstract available


  417. WHELTON P
    SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE.
    J Hypertens. 2016;34 Suppl 1:e378.
    PubMed     Text format     Abstract available


  418. BAKRIS G
    DB 03-2 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (CON).
    J Hypertens. 2016;34 Suppl 1:e375.
    PubMed     Text format     Abstract available


  419. SCHLAICH M
    DB 03-1 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (PRO).
    J Hypertens. 2016;34 Suppl 1:e375.
    PubMed     Text format     Abstract available


  420. SHI L
    ED 08-4 DIAGNOSIS AND TREATMENT OF HYPERTENSIVE EMERGENCY IN CHILDREN.
    J Hypertens. 2016;34 Suppl 1:e373-4.
    PubMed     Text format     Abstract available


  421. AWAZU M
    ED 08-3 APPLICATION OF ABP MONITORING IN THE MANAGEMENT OF PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e373.
    PubMed     Text format     Abstract available


  422. DAVIES PF, Manduchi E, Stoeckert CJ, Jiang YZ, et al
    SY 15-2 ENDOTHELIAL EPIGENETICS AND ITS ROLE IN MEDIATING BIOMECHANICAL STRESS OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e371.
    PubMed     Text format     Abstract available


  423. SCHIFFRIN E
    SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS.
    J Hypertens. 2016;34 Suppl 1:e371.
    PubMed     Text format     Abstract available


  424. TSIMPLOULIS A, Doumas M, Pittaras A, Faselis C, et al
    YIA 01-06 CARDIORESPIRATORY FITNESS AND MORTALITY RISK IN HYPERTENSIVE MEN >/=70 YEARS.
    J Hypertens. 2016;34 Suppl 1:e37-8.
    PubMed     Text format     Abstract available


  425. MORISHITA R
    SY 14-4 VACCINE THERAPY FOR RESISTANT HYPERTENSION: IS IT A DYING ISSUE?
    J Hypertens. 2016;34 Suppl 1:e369-70.
    PubMed     Text format     Abstract available


  426. CALHOUN D
    SY 14-3 PRIMARY ALDOSTERONISM IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e369.
    PubMed     Text format     Abstract available


  427. VONGPATANASIN W
    SY 14-1 THERAPEUTIC DRUG MONITORING FACILITATES BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e369.
    PubMed     Text format     Abstract available


  428. DANIELS SR
    SY 13-2 LONG-TERM CARDIOVASCULAR RISK REDUCTION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e368.
    PubMed     Text format     Abstract available


  429. BURRELL L
    SY 12-1 RENIN ANGIOTENSIN PATHWAY BEYOND ACE AND ANGIOTENSIN II RECEPTORS: HOW IT RELATES TO THE PATHOPHYSIOLOGY OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e367.
    PubMed     Text format     Abstract available


  430. RYAN MJ
    SY 11-4 CONNECTIVE TISSUE DISEASE AND ITS ASSOCIATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e366.
    PubMed     Text format     Abstract available


  431. OPARIL S
    SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?
    J Hypertens. 2016;34 Suppl 1:e366.
    PubMed     Text format     Abstract available


  432. KJELDSEN S
    PL 03-3 THE FUTURE DEVELOPMENT OF DRUG THERAPY FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e365.
    PubMed     Text format     Abstract available


  433. IMAI Y
    PL 03-2 REMOTE BLOOD PRESSURE MONITORING IN HYPERTENSION CARE: PRACTICE OF HYPERTENSION BY TELETRANSMISSION OF HOME BLOOD PRESSURE.
    J Hypertens. 2016;34 Suppl 1:e364-5.
    PubMed     Text format     Abstract available


  434. STEINHUBL S
    PL 03-1 HYPERTENSION MANAGEMENT IN THE ERA OF DIGITAL INFORMATION AND COMMUNICATION TECHNOLOGIES.
    J Hypertens. 2016;34 Suppl 1:e364.
    PubMed     Text format     Abstract available


  435. KUWABARA M, Hoshide S, Hamasaki H, Shiga T, et al
    YIA 01-04 HYPOXIA-INDUCED SURGE NOCTURNAL HYPERTENSION IDENTIFIED BY OXYGEN-TRIGGERED NOCTURNAL BLOOD PRESSURE MONITORING IN SLEEP APNEA SYNDROME.
    J Hypertens. 2016;34 Suppl 1:e36-7.
    PubMed     Text format     Abstract available


  436. LEE HY, Park CS, Na SH, Kim KJ, et al
    ISH AHA-2 A CASE OF CHRONIC INDOLENT PHEOCHROMOCYTOMA WHICH CAUSED MEDICALLY-CONTROLLED HYPERTENSION BUT TREATMENT-RESISTANT DIABETES MELLITUS.
    J Hypertens. 2016;34 Suppl 1:e35.
    PubMed     Text format     Abstract available


  437. LEE CJ, Woo Y, Kim BK, Yoon KB, et al
    ISH AHA-1 A CASE OF REFRACTORY HYPERTENSION CONTROLLED BY REPEATED RENAL DENERVATION AND CELIAC PLEXUS BLOCK: A CASE OF REFRACTORY SYMPATHETIC OVERLOAD.
    J Hypertens. 2016;34 Suppl 1:e35.
    PubMed     Text format     Abstract available


  438. PARK JB
    POA 02-4 BLOOD PRESSURE BEHAVIORS APPROACH FOR HYPERTENSION MANAGEMENT.
    J Hypertens. 2016;34 Suppl 1:e33-4.
    PubMed     Text format     Abstract available


  439. TOUYZ RM
    POA 02-3 SMALL VESSEL DISEASE AND HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e33.
    PubMed     Text format     Abstract available


  440. AVOLIO A
    POA 02-2 ATHEROGENIC VASCULAR STIFFNESS AND HYPERTENSION: CAUSE OR EFFECT?
    J Hypertens. 2016;34 Suppl 1:e33.
    PubMed     Text format     Abstract available


  441. DOMINICZAK AF
    POA 02-1 GENETIC BASIS OF BLOOD PRESSURE AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e33.
    PubMed     Text format     Abstract available


  442. LI Y
    CHL 01-3 MORNING AND NOCTURNAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e31.
    PubMed     Text format     Abstract available


  443. CHEN CH
    CHL 01-2 CENTRAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e31.
    PubMed     Text format     Abstract available


  444. STERN N
    BR 02-2 HYPERTENSION MANAGEMENT IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY.
    J Hypertens. 2016;34 Suppl 1:e30.
    PubMed     Text format     Abstract available


  445. KIM YJ
    BR 02-1 MANAGEMENT OF HYPERTENSION IN SEVERE AORTIC STENOSIS.
    J Hypertens. 2016;34 Suppl 1:e30.
    PubMed     Text format     Abstract available


  446. KARIO K
    ME 01-2 ASSESSMENT AND TREATMENT OF MORNING HYPERTENSION: UPDATE.
    J Hypertens. 2016;34 Suppl 1:e29.
    PubMed     Text format     Abstract available


  447. SATOH F
    SP 01-2 HYPERTENSIVE TARGET ORGAN DAMAGE IN PRIMARY ALDOSTERONISM.
    J Hypertens. 2016;34 Suppl 1:e28.
    PubMed     Text format     Abstract available


  448. FUJITA T
    SP 01-1 ALDOSTERONE ANTAGONISTS FOR THE TREATMENT OF HYPERTENSIVE NEPHROPATHY.
    J Hypertens. 2016;34 Suppl 1:e28.
    PubMed     Text format     Abstract available


  449. SHIRAI K
    HW 01-4 CARDIOANKLE VASCULAR INDEX (CAVI) IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e27.
    PubMed     Text format     Abstract available


  450. LEE SC
    HW 01-3 CARDIAC AND VASCULAR MRI IN HYPERTENSION EVALUATION.
    J Hypertens. 2016;34 Suppl 1:e27.
    PubMed     Text format     Abstract available


  451. JAMERSON K
    DB 01-1 RACIAL AND ETHNIC DIFFERENCES EXIST IN TERMS OF EFFICACY OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE MEDICATIONS (PRO).
    J Hypertens. 2016;34 Suppl 1:e26.
    PubMed     Text format     Abstract available


  452. SUGIURA T, Takase H, Murai S, Yamashiya S, et al
    OS 30-04 FUTURE HYPERTENSION CAN BE PREDICTED USING ELECTROCARDIOGRAM.
    J Hypertens. 2016;34 Suppl 1:e255-6.
    PubMed     Text format     Abstract available


  453. GAFAROV V, Gromova E, Panov D, Gagulin I, et al
    OS 30-03 GENDER DIFFERENCES OF AN ARTERIAL HYPERTENSION RISK IN POPULATION WITH SLEEP DISTURBANCE IN RUSSIA / SIBERIA: WHO PROGRAM MONICA-PSYCHOSOCIAL.
    J Hypertens. 2016;34 Suppl 1:e255.
    PubMed     Text format     Abstract available


  454. DENTON K, Moritz K, Booth L, May C, et al
    OS 29-06 RESPONSE TO HEMORRHAGE FOLLOWING CATHETER-BASED RENAL DENERVATION IN SHEEP WITH HYPERTENSIVE KIDNEY DISEASE.
    J Hypertens. 2016;34 Suppl 1:e254.
    PubMed     Text format     Abstract available


  455. LI X, Hong M, Zhu D, Gao P, et al
    OS 29-05 RENAL DENERVATION ATTENUATES ALDOSTERONE EXPRESSION AND ASSOCIATED CARDIOVASCULAR PATHOPHYSIOLOGY IN ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e254.
    PubMed     Text format     Abstract available


  456. LIM JK, Burke S, Head G
    OS 29-01 TRANS-GENERATIONAL PROGRAMMING OF OBESITY RELATED HYPERTENSION: AMPLIFICATION OF LEPTIN SIGNALLING PATHWAY.
    J Hypertens. 2016;34 Suppl 1:e253.
    PubMed     Text format     Abstract available


  457. YADAV R, Yadav RK, Khadgawat R, Mehta N, et al
    OS 28-06 BENEFICIAL EFFECTS OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND ADIPOKINES IN SUBJECTS WITH PRE-HYPERTENSION OR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e252.
    PubMed     Text format     Abstract available


  458. URATA H, Devarajan S, Okamura K
    OS 28-05 ANTIHYPERTENSIVE EFFECT OF CHYMASE INHIBITORY JAPANESE WATER PEPPER INTAKE IN SALT-DEPENDENT MODERATE HYPERTENSION MOUSE MODEL AND IN HUMAN.
    J Hypertens. 2016;34 Suppl 1:e252.
    PubMed     Text format     Abstract available


  459. OTT C, Kistner I, Schmid A, Friedrich S, et al
    OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e251.
    PubMed     Text format     Abstract available


  460. SCHLAICH M, Hering D, Marusic P, Walton A, et al
    OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e251.
    PubMed     Text format     Abstract available


  461. ITO S
    ED 04-3 ASSESSMENT OF RENAL FUNCTION DURING FOLLOW UP OF HYPERTENSIVE SUBJECTS.
    J Hypertens. 2016;34 Suppl 1:e25.
    PubMed     Text format     Abstract available


  462. LI Y
    ED 04-2 ASSESSMENT OF TARGET ORGAN DAMAGE DURING ANTI-HYPERTENSIVE TREATMENT: WHAT TO USE AND HOW FREQUENTLY WE SHOULD MEASURE.
    J Hypertens. 2016;34 Suppl 1:e25.
    PubMed     Text format     Abstract available


  463. HRISTOVA K, Bogdanova V, Marinov R
    OS 27-04 PREDICTION OF LEFT VENTRICULAR DYSTOLIC DYSFUNCTION IN PATIENT WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e249-50.
    PubMed     Text format     Abstract available


  464. YOON HJ
    OS 27-03 IMPAIRED DIASTOLIC RECOVERY BEFORE DISCHARGE IS ASSOCIATED WITH RE-HOSPITALIZATION WITH HYPERTENSIVE HEART FAILURE.
    J Hypertens. 2016;34 Suppl 1:e249.
    PubMed     Text format     Abstract available


  465. KIM MN, Cho D, Shim JM, Choi JI, et al
    OS 27-01 IS HYPERTENSION A RISK FACTOR FOR RECURRENCE AFTER RADIOFREQUENCY CATHETER ABLATION IN ATRIAL FIBRILLATION?
    J Hypertens. 2016;34 Suppl 1:e249.
    PubMed     Text format     Abstract available


  466. SUN J, Steffen LM, Xi B
    OS 26-05 HOW TO ACCURATELY DEFINE PEDIATRIC HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2016;34 Suppl 1:e248.
    PubMed     Text format     Abstract available


  467. NGUI D, Qiu MJ, Mann M
    OS 26-04 TARGETING CARE GAPS IN PATIENTS WITH HYPERTENSION: A QUALITY IMPROVEMENT PROJECT UTILIZING EMR HYPERTENSION DASHBOARDS AND A CHRONIC DISEASE COORDINATOR.
    J Hypertens. 2016;34 Suppl 1:e247-8.
    PubMed     Text format     Abstract available


  468. KOCHARYAN L, Baghdasaryan L
    OS 26-02 A NEW APPROACH FOR THE MANAGEMENT AND MONITORING OF ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e247.
    PubMed     Text format     Abstract available


  469. MELIN P, Prado-Arechiga G, Pulido M, Miramontes I, et al
    OS 26-01 CLASSIFICATION OF ARTERIAL HYPERTENSION USING A COMPUTATIONAL MODEL BASED ON ARTIFICIAL MODULAR NEURAL NETWORKS.
    J Hypertens. 2016;34 Suppl 1:e247.
    PubMed     Text format     Abstract available


  470. CHAN J, Lo CS, Shi Y, Chenier I, et al
    OS 25-03 OVEREXPRESSION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F PREVENTS SYSTEMIC HYPERTENSION AND KIDNEY INJURY AND NORMALIZES RENAL RENIN-ANGIOTENSIN SYSTEM GENES EXPRESSION IN TYPE 2 DIABETIC DB/DB TRANSGENIC MICE.
    J Hypertens. 2016;34 Suppl 1:e245.
    PubMed     Text format     Abstract available


  471. LIM JK, Barzel B, Burke S
    OS 25-02 ORIGIN OF NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 1:e245.
    PubMed     Text format     Abstract available


  472. LEE JH, Baek JS, Yu JJ, Kim YH, et al
    OS 24-06 HIGH B-TYPE NATRIURETIC PEPTIDE IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE IN CHILDREN WITH HYPERTENSION ON PERITONEAL DIALYSIS.
    J Hypertens. 2016;34 Suppl 1:e244.
    PubMed     Text format     Abstract available


  473. PALL D, Katona E, Zrinyi M, Lengyel S, et al
    OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e243.
    PubMed     Text format     Abstract available


  474. SHIN MS, Park SM, Kim MN, Kim HL, et al
    OS 23-05 LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANT CORONARY ARTERIAL STENOSIS INTERACTION IN HYPERTENSIVE WOMEN.
    J Hypertens. 2016;34 Suppl 1:e242.
    PubMed     Text format     Abstract available


  475. ZHAO X, Yu J
    OS 23-04 A NOVEL HORMONE THERAPY, DROSPIRENONE WITH ESTRADIOL FOR HYPERTENSIVE POSTMENOPAUSAL WOMEN: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1:e242.
    PubMed     Text format     Abstract available


  476. KIM SA, Park JB
    OS 23-03 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e241.
    PubMed     Text format     Abstract available


  477. KIM S, Lim NK, Lee JH, Park HY, et al
    OS 22-09 Population-attributable risk of hypertension in development of Stroke: using the National Sample Cohort.
    J Hypertens. 2016;34 Suppl 1:e240.
    PubMed     Text format     Abstract available


  478. LI N, Yao X, Zhou L, Abulikem S, et al
    OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China.
    J Hypertens. 2016;34 Suppl 1:e240.
    PubMed     Text format     Abstract available


  479. PATIL M, Durairaj M, Tauseef SM
    OS 22-06 Evaluating the Health Related Quality of Life of Hypertensive Patients.
    J Hypertens. 2016;34 Suppl 1:e239.
    PubMed     Text format     Abstract available


  480. ARAKAWA K, Ibaraki A, Kawamoto Y, Inoue M, et al
    OS 22-05 Variability of urinary salt excretion in treated hypertensive patients during several years.
    J Hypertens. 2016;34 Suppl 1:e239.
    PubMed     Text format     Abstract available


  481. LEE JW, Lim NK, Lee JH, Park HY, et al
    OS 22-03 Joint effect of pre-existing hypertension and diabetes on cardiovascular diseases and mortality in the middle-aged Koreans.
    J Hypertens. 2016;34 Suppl 1:e238-9.
    PubMed     Text format     Abstract available


  482. WANG HH, Wang JJ, Lawson KD, Wong SY, et al
    OS 22-02 Hypertensive patients with multimorbidity in mainland China, Scotland, and Hong Kong: a cross-country population-based study.
    J Hypertens. 2016;34 Suppl 1:e238.
    PubMed     Text format     Abstract available


  483. LEE CJ, Oh J, Lee SH, Kang SM, et al
    OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality.
    J Hypertens. 2016;34 Suppl 1:e238.
    PubMed     Text format     Abstract available


  484. NISHIYAMA A, Sufiun A, Fujisawa Y, Rahman A, et al
    OS 21-09 DIPPING PATTERN OF BLOOD PRESSURE AND RENAL INJURY IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e237.
    PubMed     Text format     Abstract available


  485. VAVRINOVA A, Behuliak M, Zicha J
    OS 21-07 EXPRESSION OF CATECHOLAMINERGIC SYSTEM GENES IN ADRENAL MEDULLA OR SYMPATHETIC GANGLIA OF SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 1:e236-7.
    PubMed     Text format     Abstract available


  486. KROTOVA V, Khomazyuk T
    OS 20-09 DIAGNOSIS AND TREATMENT OF COGNITIVE DISORDERS IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e234.
    PubMed     Text format     Abstract available


  487. ISHIKAWA J, Toba A, Yamanaka Y, Watanabe S, et al
    OS 20-08 GENDER-ADJUSTMENT AND CUTOFF LEVELS OF CORNELL PRODUCT IN ELECTROCARDIOGRAM AMONG JAPANESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e234.
    PubMed     Text format     Abstract available


  488. SECHI L, Colussi G, Novello M, Pezzutto F, et al
    OS 20-06 DAILY ALCOHOL CONSUMPTION AFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 1:e233.
    PubMed     Text format     Abstract available


  489. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 20-05 IMPACT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS UNDERWENT SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS ON LONG-TERM CLINICAL OUTCOMES.
    J Hypertens. 2016;34 Suppl 1:e233.
    PubMed     Text format     Abstract available


  490. CHI C, Zhang Y, Wang K, Wang L, et al
    OS 20-02 HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1:e232.
    PubMed     Text format     Abstract available


  491. JUNG SM, Ryu DR, Kim CT
    OS 19-07 PRESCRIPTION PATTERN OF RAS BLOCKADE IN KOREAN HYPERTENSIVE PATIENTS WITH PROTEINURIA.
    J Hypertens. 2016;34 Suppl 1:e230.
    PubMed     Text format     Abstract available


  492. JEFFERS B, Zho D
    OS 19-02 RELATIONSHIP BETWEEN VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY (BPV) AND KIDNEY FUNCTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e228.
    PubMed     Text format     Abstract available


  493. MEENA J, Raghav P, Rustagi N
    LBOS 03-06 ANTI HYPERTENSIVE TREATMENT COMPLIANCE AND ADVERSE EFFECT PROFILE AMONG HYPERTENSION CLINIC ATTENDEES IN JODHPUR, INDIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e552.
    PubMed     Text format     Abstract available


  494. KOHLI C, Gupta K
    LBOS 03-03 ECONOMIC IMPACT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551-e552.
    PubMed     Text format     Abstract available


  495. KARAMAT F, Diemer F, Baldew S, Oehlers G, et al
    LBOS 03-02 PREHYPERTENSION AND HYPERTENSION IN URBAN SURINAME: THE HELISUR STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551.
    PubMed     Text format     Abstract available


  496. YUSUFALI A, Khatib R, Islam S, AlHabib K, et al
    LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551.
    PubMed     Text format     Abstract available


  497. DEY SK, Prabhakar P, Saini M, Joseph T, et al
    LBOS 02-05 INHIBITORS OF DOPAMINE-beta-HYDROXYLASE OBTAINED BY STRUCTURE BASED METHODS EXHIBITED ANTI-HYPERTENSIVE EFFECT IN L-NAME INDUCED HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e550.
    PubMed     Text format     Abstract available


  498. LIU D
    LBOS 02-02 TELMISARTAN REDUCING MONOCYTE MITOCHONDRIA RESPIRATORY FUNCTION IS ASSOCIATED WITH INHIBITION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL CANONICAL TYPE 3 CHANNELS IN HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e549.
    PubMed     Text format     Abstract available


  499. TAO J
    LBOS 02-01 HYPERTENSION, ALDOSTERONE AND EPC-MEDIATED ENDOTHALIAL INJURY REPAIR.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e549.
    PubMed     Text format     Abstract available


  500. VILLEVALDE S, Kobalava Z
    LBOS 01-06 INTEGRATED APPROACH IMPROVED BLOOD PRESSURE CONTROL IN NON ADHERENT MOTIVATED HYPERTENSIVE PATIENTS: PRISMA STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e548.
    PubMed     Text format     Abstract available


  501. CHO EJ, Lee HY, Sung KC, Park S, et al
    LBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e548.
    PubMed     Text format     Abstract available


  502. SEVER P, Gupta A, Thompson D, Whitehouse A, et al
    LBOS 01-04 THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547-e548.
    PubMed     Text format     Abstract available


  503. VILLEVALDE S, Kovbalava Z
    LBOS 01-03 MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    PubMed     Text format     Abstract available


  504. MARCUS Y, Haran A, Shefer G, Stern N, et al
    LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    PubMed     Text format     Abstract available


  505. POULTER N, Anjum A, Cross M, Falaschetti E, et al
    LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS: A RANDOMISED CROSS-OVER TRIAL (HARMONY).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    PubMed     Text format     Abstract available


  506. MUTHUSAMY VV
    BR 08-3 MANAGEMENT OF DYSLIPIDEMIA IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e545.
    PubMed     Text format     Abstract available


  507. PARK J
    BR 08-2 CARDIOVASCULAR RISK ASSESSMENT IN HYPERTENSIVES WITH CKD.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e544-e545.
    PubMed     Text format     Abstract available


  508. ZHU Z
    BR 08-1 HIGH SODIUM INTAKE REDUCTION IN DIABETES WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e544.
    PubMed     Text format     Abstract available


  509. PARK JB
    ME 04-2 AORTIC PWV FOR RISK STRATIFICATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e541.
    PubMed     Text format     Abstract available


  510. KIM SH
    HW 03-2 EFFECT OF CPAP ON THE TREATMENT OF RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e538.
    PubMed     Text format     Abstract available


  511. KIM BK
    HW 03-1 RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION UNDER OPTIMAL DRUG THERAPY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e538.
    PubMed     Text format     Abstract available


  512. RAIZADA M
    SY 17-4 NEURO-IMMUNE COMMUNICATION IN HYPERTENSION: A NEW THERAPEUTIC ANGLE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e535.
    PubMed     Text format     Abstract available


  513. HARRISON D
    SY 17-2 INFLAMMATION, IMMUNITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e535.
    PubMed     Text format     Abstract available


  514. VAN BALLEGOOIJEN A
    SY 16-4 VITAMIN D WITH OR WITHOUT CALCIUM SUPPLEMENTATION IN RELATION TO HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e534.
    PubMed     Text format     Abstract available


  515. XU T, Sun J, Lee AP, Yang Y, et al
    OS 37-09 LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e407.
    PubMed     Text format     Abstract available


  516. KIM D, Shim CY, Hong GR, Cho IJ, et al
    OS 37-08 ASSOCIATION OF CENTRAL HEMODYNAMICS AND NEUROHORMONAL FACTORS TO MECHANICAL ADAPTATION OF LEFT VENTRICLE IN HYPERTENSION: A STUDY WITH TWO DIMENSIONAL LAYER SPECIFIC SPECKLE TRACKING STRAIN IMAGING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e407.
    PubMed     Text format     Abstract available


  517. LIM HM, Chia YC, Ching SM
    OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e406.
    PubMed     Text format     Abstract available


  518. CHO KI, Cho EA, Heo JH, Kim HS, et al
    OS 37-04 EFFECTS OF WHITE COAT HYPERTENSION ON HEART RATE RECOVERY AND BLOOD PRESSURE RESPONSE DURING EXERCISE TESTING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e406.
    PubMed     Text format     Abstract available


  519. LEE JY, Sung KC
    OS 37-03 IMPACT OF CHANGE IN EXERCISE DOSE ON RISK OF NEWLY DEVELOPED HYPERTENSION AND DIABETES MELLITUS IN KOREAN MEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e405-e406.
    PubMed     Text format     Abstract available


  520. AMUSA G, Awokola B, Isiguzo G, Onuh J, et al
    OS 37-02 HYPERTENSION IN HIV-INFECTED ADULTS IN NORTH-CENTRAL NIGERIA: PREVALENCE, ASSOCIATED RISK FACTORS AND ASSESSMENT OF RISK USING THE FRAMINGHAM RISK SCORE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e405.
    PubMed     Text format     Abstract available


  521. KONG L, Ruan C, Gao P
    OS 36-08 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIOVASCULAR INJURY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e404.
    PubMed     Text format     Abstract available


  522. ZHONG JC, Zhang ZZ, Xu R, Chen LJ, et al
    OS 36-07 TREATMENT WITH APELIN-13 PREVENTS PRESSURE OVERLOAD-INDUCED AORTIC ADVENTITIAL REMODELING AND FIBROSIS IN HYPERTENSIVE RATS WITH TAC.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403-e404.
    PubMed     Text format     Abstract available


  523. ZUO C
    OS 36-06 OSTEOGLYCIN INHIBITS HYPERTENSIVE CARDIAC FIBROSIS THOUGH SUPPRESSION OF EGFR SIGNALING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403.
    PubMed     Text format     Abstract available


  524. WANG Q, Chang P, Xu H, Bai F, et al
    OS 36-05 TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/p-Akt PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403.
    PubMed     Text format     Abstract available


  525. WANG Q, Xie A, Xu H, Yu J, et al
    OS 36-02 ASTRAGALOSIDE IV AMELIORATED MITOCHONDRIAL OXIDATIVE STRESS IN HYPERTENSIVE MICE WITH CARDIOMYOPATHY BY REGULATING MITOCHONDRIAL Ca2+ FLUX.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e402.
    PubMed     Text format     Abstract available


  526. MAIOLINO G, Flego A, Rossi GP
    OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e401.
    PubMed     Text format     Abstract available


  527. XU J, Ge Q, Zhang J, Zhu L, et al
    OS 35-06 COMPARISON OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e401.
    PubMed     Text format     Abstract available


  528. POGLITSCH M, Ahmed AH, Resl M, Stoller A, et al
    OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e400.
    PubMed     Text format     Abstract available


  529. RYUNO H, Kamide K, Gondo Y, Kabayama M, et al
    OS 34-01 ASSOCIATION OF COMBINATION OF HYPERTENSION AND DIABETES WITH COGNITIVE FUNCTION AMONG THE 70-YEARS-OLD JAPANESE GENERAL POPULATION FROM LONGITUDINAL OBSERVATION IN THE SONIC STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e396.
    PubMed     Text format     Abstract available


  530. WANG H, Chen H
    OS 33-09 ASSOCIATION OF CLOCK GENE POLYMORPHISM WITH INSULIN RESISTANCE IN HYPERTENSION: A CASE-CONTROL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e395.
    PubMed     Text format     Abstract available


  531. CAI A, Wang L, Zhou Y, Chen J, et al
    OS 33-08 OBSTRUCTIVE SLEEP APNEA PROMOTES CARDIOVASCULAR RISK IN HYPERTENSIVE POPULATIONS: A CROSS-SECTIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e395.
    PubMed     Text format     Abstract available


  532. TANAKA M, Nishimura T, Sekioka R, Kawai T, et al
    OS 33-07 LOW SERUM ALBUMIN CONCENTRATION IN HYPERTENSIVE PATIENTS COMPLICATED BY TYPE 2 DIABETES IS ASSOCIATED WITH MICROVASCULAR COMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e394-e395.
    PubMed     Text format     Abstract available


  533. OGOLA E
    OS 33-05 HIGH PREVALENCE AND POOR CONTROL OF HYPERTENSION AND ASSOCIATED CARDIOVASCULAR RISK FACORS IN DIABETIC PATIENTS IN A RURAL HOSPITAL IN KENYA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e394.
    PubMed     Text format     Abstract available


  534. OPARIL S, Calhoun DA, Ghazi L, Dudenbostel T, et al
    OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e393.
    PubMed     Text format     Abstract available


  535. PENG L, Xia K, Zhao Z, Li D, et al
    OS 32-09 THE BENEFICIAL EFFECT OF LOSARTAN ON PLATELET AGGREGATION RESULTS FROM THE REDUCTION OF ENDOGENOUS ASYMMETRIC DIMETHYL ARGININE IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e391-e392.
    PubMed     Text format     Abstract available


  536. YANG Z, Ruixin M, Jing Y
    OS 32-02 EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON VAGINA AND CARDIAC EXPRESSION OF RAAS COMPONENTS IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e390.
    PubMed     Text format     Abstract available


  537. CHEN X, Wang S, Li J, Zhou X, et al
    OS 31-06 COMPARISON BETWEEN THE EFFECTS OF HYDROCHLOROTHIAZIDE AND INDAPAMIDE ON THE KIDNEY IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH LOSARTAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e389.
    PubMed     Text format     Abstract available


  538. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 31-04 COMPARISON OF CALCIUM CHANNEL BLOCKERS VERSUS CALCIUM CHANNEL BLOCKERS WITH RENIN ANGIOTENSIN SYSTEM BLOCKERS ON THE DEVELOPMENT OF NEW-ONSET DIABETES MELLITUS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388-e389.
    PubMed     Text format     Abstract available


  539. GIULIETTI F, Spannella F, Borioni E, Lombardi FE, et al
    OS 31-03 CLINICAL EFFECTIVENESS OF ANTI-HYPERTENSIVE THERAPY WITH ACEI OR ARB ASSESSED BY PLASMA RENIN ACTIVITY/PLASMA ALDOSTERONE CONCENTRATION RATIO.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388.
    PubMed     Text format     Abstract available


  540. ZENG W, Chu T, Hu M, Kong A, et al
    OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388.
    PubMed     Text format     Abstract available


  541. KIM CH
    APSH PRE-1 WHAT CAN BE IMPROVED IN THE MANAGEMENT OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e387.
    PubMed     Text format     Abstract available


  542. KANG YY, Li Y, Huang QF, Song J, et al
    APSH YI-05 CIGARETTE SMOKING AND MASKED HYPERTENSION IN CHINESE MEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e386.
    PubMed     Text format     Abstract available


  543. LEE CJ, Oh J, Lee SH, Kang SM, et al
    APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e385.
    PubMed     Text format     Abstract available


  544. TOUYZ RM
    ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e384.
    PubMed     Text format     Abstract available


  545. SAFAR ME
    ISH PRE-1 REDUCTION OF CARDIOVASCULAR MORTALITY IN HYPERTENSIVES WITH COMORBIDITIES: BEYOND BLOOD PRESSURE LOWERING - THE ROLE OF ARTERIAL AGING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e384.
    PubMed     Text format     Abstract available


  546. POGLITSCH M
    JS ISH-ECCR-4 THE PLASMA ALDOSTERONE / ANGIOTENSIN II RATIO FOR THE SCREENING OF SECONDARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e382-e383.
    PubMed     Text format     Abstract available


  547. ROSSI GP
    JS ISH-ECCR-3 A NOVEL ALGORITHM FOR THE CASE DETECTION OF THE MOST COMMON FORM OF ENDOCRINE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e382.
    PubMed     Text format     Abstract available


  548. FUJITA T
    ME 03-1 ROLE OF ALDOSTERNE AND MINERALOCORTICOID RECEPTOR IN SALT-SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e379.
    PubMed     Text format     Abstract available


  549. WHELTON P
    SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e378.
    PubMed     Text format     Abstract available


  550. BAKRIS G
    DB 03-2 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (CON).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e375.
    PubMed     Text format     Abstract available


  551. SCHLAICH M
    DB 03-1 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e375.
    PubMed     Text format     Abstract available


  552. SHI L
    ED 08-4 DIAGNOSIS AND TREATMENT OF HYPERTENSIVE EMERGENCY IN CHILDREN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e373-e374.
    PubMed     Text format     Abstract available


  553. AWAZU M
    ED 08-3 APPLICATION OF ABP MONITORING IN THE MANAGEMENT OF PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e373.
    PubMed     Text format     Abstract available


  554. DAVIES PF, Manduchi E, Stoeckert CJ, Jiang YZ, et al
    SY 15-2 ENDOTHELIAL EPIGENETICS AND ITS ROLE IN MEDIATING BIOMECHANICAL STRESS OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e371.
    PubMed     Text format     Abstract available


  555. SCHIFFRIN E
    SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e371.
    PubMed     Text format     Abstract available


  556. MORISHITA R
    SY 14-4 VACCINE THERAPY FOR RESISTANT HYPERTENSION: IS IT A DYING ISSUE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369-e370.
    PubMed     Text format     Abstract available


  557. CALHOUN D
    SY 14-3 PRIMARY ALDOSTERONISM IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369.
    PubMed     Text format     Abstract available


  558. VONGPATANASIN W
    SY 14-1 THERAPEUTIC DRUG MONITORING FACILITATES BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369.
    PubMed     Text format     Abstract available


  559. DANIELS SR
    SY 13-2 LONG-TERM CARDIOVASCULAR RISK REDUCTION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e368.
    PubMed     Text format     Abstract available


  560. BURRELL L
    SY 12-1 RENIN ANGIOTENSIN PATHWAY BEYOND ACE AND ANGIOTENSIN II RECEPTORS: HOW IT RELATES TO THE PATHOPHYSIOLOGY OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e367.
    PubMed     Text format     Abstract available


  561. RYAN MJ
    SY 11-4 CONNECTIVE TISSUE DISEASE AND ITS ASSOCIATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e366.
    PubMed     Text format     Abstract available


  562. OPARIL S
    SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e366.
    PubMed     Text format     Abstract available


  563. KJELDSEN S
    PL 03-3 THE FUTURE DEVELOPMENT OF DRUG THERAPY FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e365.
    PubMed     Text format     Abstract available


  564. IMAI Y
    PL 03-2 REMOTE BLOOD PRESSURE MONITORING IN HYPERTENSION CARE: PRACTICE OF HYPERTENSION BY TELETRANSMISSION OF HOME BLOOD PRESSURE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e364-e365.
    PubMed     Text format     Abstract available


  565. STEINHUBL S
    PL 03-1 HYPERTENSION MANAGEMENT IN THE ERA OF DIGITAL INFORMATION AND COMMUNICATION TECHNOLOGIES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e364.
    PubMed     Text format     Abstract available


  566. SUGIURA T, Takase H, Murai S, Yamashiya S, et al
    OS 30-04 FUTURE HYPERTENSION CAN BE PREDICTED USING ELECTROCARDIOGRAM.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e255-e256.
    PubMed     Text format     Abstract available


  567. GAFAROV V, Gromova E, Panov D, Gagulin I, et al
    OS 30-03 GENDER DIFFERENCES OF AN ARTERIAL HYPERTENSION RISK IN POPULATION WITH SLEEP DISTURBANCE IN RUSSIA / SIBERIA: WHO PROGRAM MONICA-PSYCHOSOCIAL.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e255.
    PubMed     Text format     Abstract available


  568. DENTON K, Moritz K, Booth L, May C, et al
    OS 29-06 RESPONSE TO HEMORRHAGE FOLLOWING CATHETER-BASED RENAL DENERVATION IN SHEEP WITH HYPERTENSIVE KIDNEY DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e254.
    PubMed     Text format     Abstract available


  569. LI X, Hong M, Zhu D, Gao P, et al
    OS 29-05 RENAL DENERVATION ATTENUATES ALDOSTERONE EXPRESSION AND ASSOCIATED CARDIOVASCULAR PATHOPHYSIOLOGY IN ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e254.
    PubMed     Text format     Abstract available


  570. LIM JK, Burke S, Head G
    OS 29-01 TRANS-GENERATIONAL PROGRAMMING OF OBESITY RELATED HYPERTENSION: AMPLIFICATION OF LEPTIN SIGNALLING PATHWAY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e253.
    PubMed     Text format     Abstract available


  571. YADAV R, Yadav RK, Khadgawat R, Mehta N, et al
    OS 28-06 BENEFICIAL EFFECTS OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND ADIPOKINES IN SUBJECTS WITH PRE-HYPERTENSION OR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e252.
    PubMed     Text format     Abstract available


  572. URATA H, Devarajan S, Okamura K
    OS 28-05 ANTIHYPERTENSIVE EFFECT OF CHYMASE INHIBITORY JAPANESE WATER PEPPER INTAKE IN SALT-DEPENDENT MODERATE HYPERTENSION MOUSE MODEL AND IN HUMAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e252.
    PubMed     Text format     Abstract available


  573. OTT C, Kistner I, Schmid A, Friedrich S, et al
    OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e251.
    PubMed     Text format     Abstract available


  574. SCHLAICH M, Hering D, Marusic P, Walton A, et al
    OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e251.
    PubMed     Text format     Abstract available


  575. HRISTOVA K, Bogdanova V, Marinov R
    OS 27-04 PREDICTION OF LEFT VENTRICULAR DYSTOLIC DYSFUNCTION IN PATIENT WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249-e250.
    PubMed     Text format     Abstract available


  576. YOON HJ
    OS 27-03 IMPAIRED DIASTOLIC RECOVERY BEFORE DISCHARGE IS ASSOCIATED WITH RE-HOSPITALIZATION WITH HYPERTENSIVE HEART FAILURE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249.
    PubMed     Text format     Abstract available


  577. KIM MN, Cho D, Shim JM, Choi JI, et al
    OS 27-01 IS HYPERTENSION A RISK FACTOR FOR RECURRENCE AFTER RADIOFREQUENCY CATHETER ABLATION IN ATRIAL FIBRILLATION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249.
    PubMed     Text format     Abstract available


  578. SUN J, Steffen LM, Xi B
    OS 26-05 HOW TO ACCURATELY DEFINE PEDIATRIC HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e248.
    PubMed     Text format     Abstract available


  579. NGUI D, Qiu MJ, Mann M
    OS 26-04 TARGETING CARE GAPS IN PATIENTS WITH HYPERTENSION: A QUALITY IMPROVEMENT PROJECT UTILIZING EMR HYPERTENSION DASHBOARDS AND A CHRONIC DISEASE COORDINATOR.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247-e248.
    PubMed     Text format     Abstract available


  580. KOCHARYAN L, Baghdasaryan L
    OS 26-02 A NEW APPROACH FOR THE MANAGEMENT AND MONITORING OF ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247.
    PubMed     Text format     Abstract available


  581. MELIN P, Prado-Arechiga G, Pulido M, Miramontes I, et al
    OS 26-01 CLASSIFICATION OF ARTERIAL HYPERTENSION USING A COMPUTATIONAL MODEL BASED ON ARTIFICIAL MODULAR NEURAL NETWORKS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247.
    PubMed     Text format     Abstract available


  582. CHAN J, Lo CS, Shi Y, Chenier I, et al
    OS 25-03 OVEREXPRESSION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F PREVENTS SYSTEMIC HYPERTENSION AND KIDNEY INJURY AND NORMALIZES RENAL RENIN-ANGIOTENSIN SYSTEM GENES EXPRESSION IN TYPE 2 DIABETIC DB/DB TRANSGENIC MICE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e245.
    PubMed     Text format     Abstract available


  583. LIM JK, Barzel B, Burke S
    OS 25-02 ORIGIN OF NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e245.
    PubMed     Text format     Abstract available


  584. LEE JH, Baek JS, Yu JJ, Kim YH, et al
    OS 24-06 HIGH B-TYPE NATRIURETIC PEPTIDE IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE IN CHILDREN WITH HYPERTENSION ON PERITONEAL DIALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e244.
    PubMed     Text format     Abstract available


  585. PALL D, Katona E, Zrinyi M, Lengyel S, et al
    OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e243.
    PubMed     Text format     Abstract available


  586. SHIN MS, Park SM, Kim MN, Kim HL, et al
    OS 23-05 LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANT CORONARY ARTERIAL STENOSIS INTERACTION IN HYPERTENSIVE WOMEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e242.
    PubMed     Text format     Abstract available


  587. ZHAO X, Yu J
    OS 23-04 A NOVEL HORMONE THERAPY, DROSPIRENONE WITH ESTRADIOL FOR HYPERTENSIVE POSTMENOPAUSAL WOMEN: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e242.
    PubMed     Text format     Abstract available


  588. KIM SA, Park JB
    OS 23-03 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e241.
    PubMed     Text format     Abstract available


  589. KIM S, Lim NK, Lee JH, Park HY, et al
    OS 22-09 Population-attributable risk of hypertension in development of Stroke: using the National Sample Cohort.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e240.
    PubMed     Text format     Abstract available


  590. LI N, Yao X, Zhou L, Abulikem S, et al
    OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e240.
    PubMed     Text format     Abstract available


  591. PATIL M, Durairaj M, Tauseef SM
    OS 22-06 Evaluating the Health Related Quality of Life of Hypertensive Patients.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e239.
    PubMed     Text format     Abstract available


  592. ARAKAWA K, Ibaraki A, Kawamoto Y, Inoue M, et al
    OS 22-05 Variability of urinary salt excretion in treated hypertensive patients during several years.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e239.
    PubMed     Text format     Abstract available


  593. LEE JW, Lim NK, Lee JH, Park HY, et al
    OS 22-03 Joint effect of pre-existing hypertension and diabetes on cardiovascular diseases and mortality in the middle-aged Koreans.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238-e239.
    PubMed     Text format     Abstract available


  594. WANG HH, Wang JJ, Lawson KD, Wong SY, et al
    OS 22-02 Hypertensive patients with multimorbidity in mainland China, Scotland, and Hong Kong: a cross-country population-based study.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238.
    PubMed     Text format     Abstract available


  595. LEE CJ, Oh J, Lee SH, Kang SM, et al
    OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238.
    PubMed     Text format     Abstract available


  596. NISHIYAMA A, Sufiun A, Fujisawa Y, Rahman A, et al
    OS 21-09 DIPPING PATTERN OF BLOOD PRESSURE AND RENAL INJURY IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e237.
    PubMed     Text format     Abstract available


  597. VAVRINOVA A, Behuliak M, Zicha J
    OS 21-07 EXPRESSION OF CATECHOLAMINERGIC SYSTEM GENES IN ADRENAL MEDULLA OR SYMPATHETIC GANGLIA OF SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e236-e237.
    PubMed     Text format     Abstract available


  598. KROTOVA V, Khomazyuk T
    OS 20-09 DIAGNOSIS AND TREATMENT OF COGNITIVE DISORDERS IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e234.
    PubMed     Text format     Abstract available


  599. ISHIKAWA J, Toba A, Yamanaka Y, Watanabe S, et al
    OS 20-08 GENDER-ADJUSTMENT AND CUTOFF LEVELS OF CORNELL PRODUCT IN ELECTROCARDIOGRAM AMONG JAPANESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e234.
    PubMed     Text format     Abstract available


  600. SECHI L, Colussi G, Novello M, Pezzutto F, et al
    OS 20-06 DAILY ALCOHOL CONSUMPTION AFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e233.
    PubMed     Text format     Abstract available


  601. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 20-05 IMPACT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS UNDERWENT SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS ON LONG-TERM CLINICAL OUTCOMES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e233.
    PubMed     Text format     Abstract available


  602. CHI C, Zhang Y, Wang K, Wang L, et al
    OS 20-02 HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e232.
    PubMed     Text format     Abstract available


  603. JUNG SM, Ryu DR, Kim CT
    OS 19-07 PRESCRIPTION PATTERN OF RAS BLOCKADE IN KOREAN HYPERTENSIVE PATIENTS WITH PROTEINURIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e230.
    PubMed     Text format     Abstract available


  604. JEFFERS B, Zho D
    OS 19-02 RELATIONSHIP BETWEEN VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY (BPV) AND KIDNEY FUNCTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e228.
    PubMed     Text format     Abstract available


  605. ZHANG Y, Lu Y, Bai B, Yu S, et al
    OS 18-09 COMPARISON OF CAROTID-FEMORAL AND BRACHIAL-ANKLE PULSE WAVE VELOCITY IN THE ASSOCIATION WITH HYPERTENSIVE TARGET ORGAN DAMAGES IN THE COMMUNITY-DWELLING ELDERLY: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e226-e227.
    PubMed     Text format     Abstract available


  606. UCHIWA H, Kai H, Iwamoto Y, Anegawa T, et al
    OS 18-07 SAFETY AND EFFICACY OF ARB/HCTZ COMBINATION THERAPY IN CONTROLLING MORNING HYPERTENSION IN VERY ELDERLY PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e226.
    PubMed     Text format     Abstract available


  607. TRIAM-ANURUCK U, Vathesatogkit P, Yingchoncharoen T, Katekao W, et al
    OS 18-04 HYPERTENSION AS A PREDICTOR OF PATTERN OF LV HYPERTROPHY AND GEOMETRIC REMODELING IN ELDERLY: HAPPY MODEL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e225.
    PubMed     Text format     Abstract available


  608. BOHLENDER J, Nussberger J, Bohlender B
    OS 18-02 ANTIHYPERTENSIVE TREATMENT AND RISK OF BRAIN ISCHEMIA DUE TO CAROTID STENOSIS IN A SURVEY OF HOSPITALISED PATIENTS AGED 90 YEARS AND OLDER.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e224.
    PubMed     Text format     Abstract available


  609. DE LA COLINA AN, Wu R, Desjardins-Crepeau L, Larochelle P, et al
    OS 18-01 CORRELATION BETWEEN COGNITIVE DECLINE AND BLOOD PRESSURE IN ELDERLY PATIENTS WITH CONTROLLED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e224.
    PubMed     Text format     Abstract available


  610. WANG Z, Chen Z, Wang X, Hao G, et al
    OS 16-07 COST-EFFECTIVENESS OF NITRENDIPINE PLUS HYDROCHLOROTHIAZIDE OR METOPROLOL TO TREAT HYPERTENSION IN RURAL COMMUNITY HEALTH CENTERS IN CHINA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e220.
    PubMed     Text format     Abstract available


  611. REYNOLDS K, Shimbo D, Bowling CB, Deng L, et al
    OS 16-06 RISK FACTORS FOR SERIOUS FALL INJURIES FOLLOWING INITIATION OF ANTIHYPERTENSIVE MEDICATION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219-e220.
    PubMed     Text format     Abstract available


  612. KAUSER M, Sr V, Rc K, Afreen A, et al
    OS 16-05 STUDY OF DETERMINANTS OF NONADHERENCE TO ANTI-HYPERTENSIVE MEDICATIONS IN ESSENTIAL HYPERTENSION AT A TEACHING HOSPITAL IN SOUTHERN INDIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219.
    PubMed     Text format     Abstract available


  613. CHANG C, Zeng Q, Ji Y, Sun X, et al
    OS 16-04 EFFECTS OF HEALTH LITERACY ON BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE: A MEDIATING EFFECT ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219.
    PubMed     Text format     Abstract available


  614. YU Q, Liu B, Na R
    OS 16-01 THE EPIDEMIOLOGY SURVEY OF THE PREVALENCE AND RISK FACTORS OF HYPERTENSION AMONG RESIDENTS IN COUNTRY OF DALIAN ZHUANGHE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e218.
    PubMed     Text format     Abstract available


  615. HOOD KY, Yusuf H, Findlay JE, Santos RA, et al
    OS 15-08 Ang(1-7) INFLUENCES ET-1 SIGNALING THROUGH MAS: ETBR INTERACTIONS: IMPLICATIONS IN PULMONARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e216.
    PubMed     Text format     Abstract available


  616. KIM YG, Lee S, Moon JY, Kim SY, et al
    OS 15-06 SEQUENTIAL ACTIVATION OF INTRARENAL ACE/ACE2 AS THE PROGRESSION OF HYPERTENSIVE NEPHROPATHY IN 2-KIDNEY 10CLIP (2K1C) GOLDBLATT RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e216.
    PubMed     Text format     Abstract available


  617. SEO M, Sung KC
    OS 14-05 THE EFFECT OF URINARY ALBUMIN AND HYPERTENSION IN ALL-CAUSE AND CVD MORTALITY IN EAST ASIAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e213.
    PubMed     Text format     Abstract available


  618. SALVETTI M, Paini A, Rosei CA, Stassaldi D, et al
    OS 14-02 ON TREATMENT BLOOD PRESSURE VALUES AND CARDIAC ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e212.
    PubMed     Text format     Abstract available


  619. ZHANG X, Zhang Y, Liu L, Zanchetti A, et al
    OS 14-01 AN ESTIMATED OPTIMAL HYPERTENSION LEVEL OF GOALS ON DRUG THERAPY FROM THE FEVER TRIAL.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e212.
    PubMed     Text format     Abstract available


  620. ZHANG Y, Chi C, Yu S, Argyris A, et al
    OS 13-08 ASSOCIATION OF CARDIAC STRUCTURE AND FUNCTION WITH CENTRAL AND BRACHIAL BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: THE SAFAR STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e210.
    PubMed     Text format     Abstract available


  621. CHENG YB, Xu TY, Yang Y, Guo QH, et al
    OS 13-05 PREVALENCE OF CENTRAL HYPERTENSION AND ITS ASSOCIATION WITH TARGET ORGAN DAMAGE IN UNTREATED CHINESE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e209.
    PubMed     Text format     Abstract available


  622. SALADINI F, Benetti E, Fania C, Mos L, et al
    OS 13-02 ASSOCIATION BETWEEN URIC ACID, METABOLIC VARIABLES AND ARTERIAL STIFFNESS IN THE EARLY PHASE OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e208.
    PubMed     Text format     Abstract available


  623. PANDEY D, Tori D, Nomura Y, Berkowitz D, et al
    YIA 03-10 ENDOTHELIAL KRUPPEL-LIKE FACTOR 15: A NOVEL TARGET FOR THE TREATMENT OF PULMONARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e206-e207.
    PubMed     Text format     Abstract available


  624. RAMADHIANI R, Rohman MS, Widodo N, Putri VY, et al
    YIA 03-05 BLOOD PRESSURE REDUCTION AND DIFFERENT C/EBPalpha-DNA BINDING PATTERN IN TELMISARTAN-TREATED ANGIOTENSINOGEN G-217A POLYMORPHISM HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e205.
    PubMed     Text format     Abstract available


  625. BEHULIAK M, Bencze M, Vavrinova A, Vaneckova I, et al
    YIA 03-03 EFFECT OF GABAPENTIN, LIGAND OF ALPHA 2 DELTA SUBUNIT OF VOLTAGE-DEPENDENT CALCIUM CHANNELS, ON BLOOD PRESSURE AND BAROREFLEX SENSITIVITY IN SPONTANEOUSLY HYPERTENSIVE RATS: THE INFLUENCE OF GUANETHIDINE-INDUCED SYMPATHECTOMY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e204.
    PubMed     Text format     Abstract available


  626. RUAN CC, Li Y, Ma Y, Zhu DL, et al
    YIA 03-02 ADIPONECTIN-MEDIATED EPITHELIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL FIBROSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e204.
    PubMed     Text format     Abstract available


  627. PERI-OKONNY P, Ayers C, Maalouf N, Das S, et al
    YIA 02-04 RELATIONSHIP BETWEEN LEPTIN AND INCIDENT HYPERTENSION; OBSERVATIONS FROM THE DALLAS HEART STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e203.
    PubMed     Text format     Abstract available


  628. SUNG KC
    JS KSH-JSH-CHL 01-2 HYPERTENSION, ADDITIONAL MAKERS AND MORTALITY IN SUBJECTS WITH METABOLIC SYNDROME: BIG DATA ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e200.
    PubMed     Text format     Abstract available


  629. ITOH H
    JS KSH-JSH-CHL 01-1 CARDIO-METABOLIC RISKS IN HYPERTENSION: ARE WE DIFFERENT FROM WESTERN SOCIETIES?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e200.
    PubMed     Text format     Abstract available


  630. YIM DS
    BR 04-2 CONCENTRATION-RESPONSE MODELING OF ANTIHYPERTENSIVE DRUGS - IMPLICATION IN CLINICAL DEVELOPMENT.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e198.
    PubMed     Text format     Abstract available


  631. WEBB DJ
    BR 04-1MANAGEMENT OF TREATMENT-RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e198.
    PubMed     Text format     Abstract available


  632. CARLBERG B
    ME 02-1 IS LOWER REALLY BETTER? ISSUE OF THE J CURVE HYPOTHESIS IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e196.
    PubMed     Text format     Abstract available


  633. TOMASZEWSKI M
    SP 03-2 ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE TREATMENT BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HP LC-MS/MS) URINE ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e195.
    PubMed     Text format     Abstract available


  634. SCHIFFRIN E
    SP 02-5 DO WE NEED A NEW DEFINITION OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e194.
    PubMed     Text format     Abstract available


  635. CUSHMAN WC
    JS ISH-ESH-4 WHAT DO CLINICAL TRIALS TEACH US ABOUT SELECTION OF ANTIHYPERTENSIVE DRUGS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e193.
    PubMed     Text format     Abstract available


  636. DECHEND R
    JS ISH-ESH-3 RESISTANT HYPERTENSION - A GROWING CHALLENGE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e193.
    PubMed     Text format     Abstract available


  637. ROSEI EA
    JS ISH-ESH-2 UPDATE ON THE DETECTION AND FOLLOW-UP OF EARLY HYPERTENSIVE HEART DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e192-e193.
    PubMed     Text format     Abstract available


  638. BAKRIS G
    JS ISH-ISN-2 ROLE OF THE KIDNEY IN RESISTANT HYPERTENSION: WHY SO RESISTANT TO BP CONTROL IN CKD PATIENTS?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e191.
    PubMed     Text format     Abstract available


  639. WILCOX C
    JS ISH-ISN-1 OXIDATIVE STRESS, THE KIDNEY AND HYPERTENSION CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e191.
    PubMed     Text format     Abstract available


  640. APPEL L
    DB 02-3 STRICT CONTROL OF HYPERTENSION IN THE ELDERLY WITH DIABETES AND CHRONIC KIDNEY DISEASE (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    PubMed     Text format     Abstract available


  641. RAKUGI H
    DB 02-2 STRICT CONTROL OF HYPERTENSION IN THE FRAIL ELDERLY: IS IT BENEFICIAL? (CON).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    PubMed     Text format     Abstract available


  642. KIM KI
    DB 02-1 STRICT CONTROL OF HYPERTENSION IN THE FRAIL ELDERLY: IS IT BENEFICIAL? (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    PubMed     Text format     Abstract available


  643. SHARMAN J
    ED 07-4 IS EXERCISE-INDUCED HYPERTENSION ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    PubMed     Text format     Abstract available


  644. KOKKINOS P
    ED 07-2 TO LIFT, WALK OR RUN: WHAT IS THE OPTIMAL MODE OF EXERCISE TO REDUCE HYPERTENSION AND PREVENT CARDIOVASCULAR DISEASE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    PubMed     Text format     Abstract available


  645. JAE SY
    ED 07-1 CONTRIBUTION OF CARDIOPULMONARY FITNESS IN OBESITY PHENOTYPES AND INCIDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    PubMed     Text format     Abstract available


  646. SARZANI R
    ED 05-4 NATRIURETIC PEPTIDES, METABOLIC SYNDROME AND HYPERTENSION: AN INTEGRATED VIEW.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e187.
    PubMed     Text format     Abstract available


  647. MERTENS P
    SY 10-3 SGLT2 INHIBITORS AS POTENTIAL ANTIHYPERTENSIVE AND RENOPROTECTIVE AGENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e186.
    PubMed     Text format     Abstract available


  648. NISHIYAMA A
    SY 09-3 ROLE OF INTRARENAL RAS IN THE PATHOGENESIS OF SALT-DEPENDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e184-e185.
    PubMed     Text format     Abstract available


  649. SHIMADA K
    SY 08-2 HYPERTENSION MANAGEMENT FOR SECONDARY PREVENTION OF STROKE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e183.
    PubMed     Text format     Abstract available


  650. WEBER M
    PL 02-3 MANAGEMENT OF ELDERLY HYPERTENSION: WHOM TO TREAT AND HOW LOW TO GO.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e182.
    PubMed     Text format     Abstract available


  651. KOKUBO Y
    PL 02-2 PERSPECTIVE ON ELDERLY HYPERTENSION IN ASIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e182.
    PubMed     Text format     Abstract available


  652. WANG W, Ma L, Sui H, Liu L, et al
    OS 12-05 THE EFFECT OF INTENSIVE LIFESTYLE INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION, SUB-ANALYSIS FROM CHIEF.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e77.
    PubMed     Text format     Abstract available


  653. KARIO K, Hoshide S
    OS 12-01 ARB AND CCB LONGEST COMBINATION TREATMENT ON AMBULATORY AND HOME BP IN HYPERTENSION WITH ATRIAL FIBRILLATION - MULTICENTER STUDY ON TIME OF DOSING (ACROBAT).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e76.
    PubMed     Text format     Abstract available


  654. SOKOLOVIC S, Mehmedagic S
    OS 11-06 The effect of vagus nerve stimulation on arterial hypertension using active implantable device.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e75.
    PubMed     Text format     Abstract available


  655. WALAS D, Von Roloff E, Paton J
    OS 11-05 Superior cervical ganglionectomy (SCGx) reduces sympathetic innervation of vertebrobasilar arteries but does not affect cerebrovascular remodelling in the adult spontaneously hypertensive rat (SHR).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e75.
    PubMed     Text format     Abstract available


  656. NISHIYAMA A, Hitomi H, Nakano D, Fujisawa Y, et al
    OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74-e75.
    PubMed     Text format     Abstract available


  657. KIM MN, Kim YB, Park SM, Kim YI, et al
    OS 11-02 Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74.
    PubMed     Text format     Abstract available


  658. WAINFORD R, Carmichael C, Walsh K
    OS 11-01 Afferent renal nerve modulation of sodium homeostasis and blood pressure: A sodium sensitive PVN Galphai2 protein dependent mechanism countering the development of salt-sensitive hypertension?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74.
    PubMed     Text format     Abstract available


  659. PAULETTO P, Puato M, Rattazzi M, Buso R, et al
    OS 10-06 THE IMPACT OF WELL CONTROLLED BLOOD PRESSURE LEVELS ON ARTERIAL PROPERTIES IN ESSENTIAL HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e73.
    PubMed     Text format     Abstract available


  660. LIU Z, Zhao Y, Dong Y, Lu B, et al
    OS 10-02 EFFECTS OF HELICOBACTER PYLORI INFECTION ON ATHEROSCLEROSIS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS IN AGED POPULATION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e72.
    PubMed     Text format     Abstract available


  661. BURSZTYN M, Ben-Dov IZ
    OS 09-03 EXTREME DIPPING IS NOT ASSOCIATED WITH INCREASED MORTALITY IN BOTH TREATED AND UNTREATED HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e70.
    PubMed     Text format     Abstract available


    August 2016
  662. ZANCHETTI A
    Genetic and environmental factors in development of hypertension.
    J Hypertens. 2016.
    PubMed     Text format    


  663. MUSICHA C, Crampin AC, Kayuni N, Koole O, et al
    Accessing clinical services and retention in care following screening for hypertension and diabetes among Malawian adults: an urban/rural comparison.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  664. ANTIKAINEN RL, Peters R, Beckett NS, Fagard RH, et al
    Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  665. KARAMAT FA, Oudman I, Haan YC, van Kuilenburg AB, et al
    Creatine kinase inhibition lowers systemic arterial blood pressure in spontaneously hypertensive rats: a randomized controlled trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  666. LEHMANN N, Erbel R, Mahabadi AA, Kalsch H, et al
    Accelerated progression of coronary artery calcification in hypertension but also prehypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  667. KIM GR, Cho SN, Kim HS, Yu SY, et al
    Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  668. WOHLFAHRT P, Cifkova R, Movsisyan N, Kunzova S, et al
    Threshold for diagnosing hypertension by automated office blood pressure using random sample population data.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  669. CHUANG SY, Chiu TH, Lee CY, Liu TT, et al
    Vegetarian diet reduces the risk of hypertension independent of abdominal obesity and inflammation: a prospective study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  670. OMBONI S, Aristizabal D, De la Sierra A, Dolan E, et al
    Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  671. SALAZAR MR, Espeche WG, Leiva Sisnieguez BC, Balbin E, et al
    Significance of masked and nocturnal hypertension in normotensive women coursing a high-risk pregnancy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  672. MUNTNER P, Booth JN 3rd, Shimbo D, Schwartz JE, et al
    Is white-coat hypertension associated with increased cardiovascular and mortality risk?
    J Hypertens. 2016;34:1655-8.
    PubMed     Text format    


  673. SCHLAICH MP, Schultz C, Shetty S
    Renal denervation for resistant hypertension: closing in on potential confounders.
    J Hypertens. 2016;34:1505-6.
    PubMed     Text format    


  674. JORDAN J, Grassi G, Tank J
    Device-based treatments in hypertension: think physiology.
    J Hypertens. 2016;34:1502-4.
    PubMed     Text format    


  675. TADDEI S, Bruno RM
    Endothelial dysfunction in hypertension: achievements and open questions.
    J Hypertens. 2016;34:1492-3.
    PubMed     Text format    


  676. KJELDSEN SE, Os I, Redon J
    Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials.
    J Hypertens. 2016;34:1489-91.
    PubMed     Text format    


  677. ZANCHETTI A
    Challenges of antihypertensive treatment.
    J Hypertens. 2016;34:1449-50.
    PubMed     Text format    


    July 2016
  678. ZANCHETTI A
    The approach to hypertension: from childhood to old age.
    J Hypertens. 2016.
    PubMed     Text format    


  679. ONWUBERE B, Coca A, Damasceno A, Kadiri S, et al
    Report of the International Society of Hypertension Teaching Seminar organized by the International Society of Hypertension Africa Regional Advisory Group: Maputo, Mozambique, 2016.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  680. LURBE E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, et al
    2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  681. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  682. DE COSMO S, Viazzi F, Piscitelli P, Giorda C, et al
    Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  683. BURSZTYN M, Jacobs JM, Hammerman-Rozenberg A, Stessman J, et al
    Prevalence of orthostatic hypertension in the very elderly and its relationship to all-cause mortality.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  684. TENTORI S, Messaggio E, Brioni E, Casamassima N, et al
    Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  685. HERRERA NA, Jesus I, Shinohara AL, Dionisio TJ, et al
    Exercise training attenuates dexamethasone-induced hypertension by improving autonomic balance to the heart, sympathetic vascular modulation and skeletal muscle microcirculation.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  686. JICHOVA S, Kopkan L, Huskova Z, Dolezelova S, et al
    Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  687. IMPRIALOS K, Boutari C, Stavropoulos K, Doumas M, et al
    Depression in hypertensive patients: the role of comorbidities.
    J Hypertens. 2016;34:1441.
    PubMed     Text format    


  688. ZANCHETTI A
    From pregnancy to childhood and adulthood: the trajectory of hypertension.
    J Hypertens. 2016;34:1235-1236.
    PubMed     Text format    


  689. NIEMIRSKA A, Litwin M, Trojanek J, Gackowska L, et al
    Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  690. HAMER M, Kivimaki M, Batty GD
    Pulse rate reactivity in childhood as a risk factor for adult hypertension: the 1970 British cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  691. MAHFOUD F, Moon LB, Pipenhagen CA, Jensen JA, et al
    Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


    June 2016
  692. SANTOS LP, Moraes RS, Vieira PJ, Ash GI, et al
    Effects of aerobic exercise intensity on ambulatory blood pressure and vascular responses in resistant hypertension: a crossover trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  693. DE SIMONE G, Izzo R, Losi MA, Stabile E, et al
    Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  694. BOMBELLI M, Maloberti A, Raina L, Facchetti R, et al
    Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  695. MAATOUK I, Herzog W, Bohlen F, Quinzler R, et al
    Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  696. OLIVERAS A, Armario P, Clara A, Sans-Atxer L, et al
    Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  697. RAUTIAINEN S, Wang L, Lee IM, Manson JE, et al
    Multivitamin use and the risk of hypertension in a prospective cohort study of women.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  698. SHIMADA K, Kario K, Kushiro T, Teramukai S, et al
    Prognostic significance of on-treatment home and clinic blood pressure for predicting cardiovascular events in hypertensive patients in the HONEST study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  699. SONG J, Sheng CS, Huang QF, Li LH, et al
    Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  700. LEEUW JV, Berra E, Gu Y, Petit T, et al
    Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?
    J Hypertens. 2016.
    PubMed     Text format    


  701. REDON J, Mourad JJ, Schmieder RE, Volpe M, et al
    Why in 2016 are patients with hypertension not 100% controlled? A call to action.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  702. LI Z, Guo X, Sun Y
    Relationship between aortic root size and glomerular filtration rate in hypertensive patients.
    J Hypertens. 2016;34:1232-3.
    PubMed     Text format    


  703. GALDERISI M, Trimarco B
    Global longitudinal strain: a novel hallmark of cardiac risk in arterial hypertension.
    J Hypertens. 2016;34:1050-1.
    PubMed     Text format    


  704. VIAZZI F, Grassi G, Pontremoli R
    Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index.
    J Hypertens. 2016;34:1047-9.
    PubMed     Text format    


    May 2016
  705. VIAZZI F, Muiesan ML, Schillaci G, Salvetti M, et al
    Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  706. OKIN PM, Kamel H, Kjeldsen SE, Devereux RB, et al
    Electrocardiographic left atrial abnormality and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  707. CHEN X, Liu Y, Wang WE, Chen C, et al
    Effect of D3 dopamine receptor on dopamine D4 receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  708. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  709. MATHIASSEN ON, Vase H, Bech JN, Christensen KL, et al
    Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  710. SOULLIER C, Niamkey JT, Ricci JE, Messner-Pellenc P, et al
    Hypertensive patients with left ventricular hypertrophy have global left atrial dysfunction and impaired atrio-ventricular coupling.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  711. STERGIOU GS, Parati G, Vlachopoulos C, Achimastos A, et al
    Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitori
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  712. VAN TWIST DJ, Houben AJ, de Leeuw PW, Kroon AA, et al
    Acute eprosartan-induced intrarenal vasodilation in hypertensive humans is not influenced by dietary sodium intake or angiotensin II co-infusion.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  713. ANDERSEN H, Hansen PB, Bistrup C, Nielsen F, et al
    Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  714. MORDI I, Mordi N, Delles C, Tzemos N, et al
    Endothelial dysfunction in human essential hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  715. IOAKEIMIDIS N, Vlachopoulos C, Rokkas K, Kratiras Z, et al
    Dynamic penile peak systolic velocity predicts major adverse cardiovascular events in hypertensive patients with erectile dysfunction.
    J Hypertens. 2016;34:860-868.
    PubMed     Text format     Abstract available


  716. NARGESI AA, Esteghamati S, Heidari B, Hafezi-Nejad N, et al
    Nonlinear relation between pulse pressure and coronary heart disease in patients with type 2 diabetes or hypertension.
    J Hypertens. 2016;34:974-80.
    PubMed     Text format     Abstract available


  717. BANG CN, Okin PM
    Does electrocardiography still have a place in hypertension?
    J Hypertens. 2016;34:842-4.
    PubMed     Text format    


  718. SPRADLEY FT
    Optimizing inhibition of the renin-angiotensin system in hypertension.
    J Hypertens. 2016;34:838-41.
    PubMed     Text format    


  719. FERREIRA I, Healy GN
    Shifting away from sedentary time, and FITTing exercise into the treatment of hypertension.
    J Hypertens. 2016;34:830-2.
    PubMed     Text format    


  720. RAHMAN A, Kittikulsuth W, Fujisawa Y, Sufiun A, et al
    Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome.
    J Hypertens. 2016;34:893-906.
    PubMed     Text format     Abstract available


  721. MARIE PY, Mandry D, Huttin O, Micard E, et al
    Comprehensive monitoring of cardiac remodeling with aortic stroke volume values provided by a phase-contrast MRI sequence.
    J Hypertens. 2016;34:967-73.
    PubMed     Text format     Abstract available


    April 2016
  722. HU T, Guralnik JM, Yao L, Gustat J, et al
    Postural hand tremor and incident hypertension in young to middle-aged adults: the Bogalusa heart study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  723. ROHLA M, Haberfeld H, Tscharre M, Huber K, et al
    Awareness, treatment, and control of hypertension in Austria: a multicentre cross-sectional study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  724. SANCHEZ-INIGO L, Navarro-Gonzalez D, Pastrana-Delgado J, Fernandez-Montero A, et al
    Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  725. CARLISLE RE, Werner KE, Yum V, Lu C, et al
    Endoplasmic reticulum stress inhibition reduces hypertension through the preservation of resistance blood vessel structure and function.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  726. LUPAT A, Hengelbrock J, Luissin M, Fix M, et al
    Brunei epidemiological stroke study: patterns of hypertension and stroke risk.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  727. FYFE-JOHNSON AL, Alonso A, Selvin E, Bower JK, et al
    Serum fibroblast growth factor-23 and incident hypertension: the atherosclerosis risk in communities study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  728. ZANCHETTI A
    Prediction, diagnosis and treatment of hypertension.
    J Hypertens. 2016.
    PubMed     Text format    


  729. LONNEBAKKEN MT, Izzo R, Mancusi C, Losi MA, et al
    Aortic root dimension and arterial stiffness in arterial hypertension: the Campania Salute Network.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  730. REDON J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, et al
    Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  731. IWASHIMA Y, Fukuda T, Yoshihara F, Kusunoki H, et al
    Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  732. ROSENBAUM D, Mattina A, Koch E, Rossant F, et al
    Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  733. BUUS NH, Mulvany MJ, Eiskjaer H, Christensen KL, et al
    Renal resistance and long-term blood pressure in individuals genetically predisposed for essential hypertension: 10-year follow-up of the Danish Hypertension Prevention Project.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  734. FUCHS FD, Scala LC, Vilela-Martin JF, de Mello RB, et al
    Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial.
    J Hypertens. 2016;34:798-806.
    PubMed     Text format     Abstract available


  735. JORDAN J, Grassi G
    Precision medicine should become more 'sympathetic' in managing hypertension.
    J Hypertens. 2016;34:629-31.
    PubMed     Text format    


  736. MANCIA G
    Clinical significance of white-coat hypertension.
    J Hypertens. 2016;34:623-6.
    PubMed     Text format    


  737. COCA A, Camafort M
    Relationship between systolic blood pressure and mortality in patients with severe cognitive impairment: extremes are bad.
    J Hypertens. 2016;34:632-3.
    PubMed     Text format    


  738. HIRAKAWA Y, Arima H, Webster R, Zoungas S, et al
    Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.
    J Hypertens. 2016;34:781-7.
    PubMed     Text format     Abstract available


  739. KERLEY CP, Dolan E, Cormican L
    Dietary nitrate decreased blood pressure in obstructive sleep apnoea syndrome: a series of N-of-1 trials.
    J Hypertens. 2016;34:808-10.
    PubMed     Text format    


  740. MISSOURIS CG, Markandu ND, He FJ, Papavasileiou MV, et al
    Urinary catecholamines and the relationship with blood pressure and pharmacological therapy.
    J Hypertens. 2016;34:704-9.
    PubMed     Text format     Abstract available


    March 2016
  741. LEE WH, Liu YW, Yang LT, Tsai WC, et al
    Prognostic value of longitudinal strain of subepicardial myocardium in patients with hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  742. KUNUTSOR SK, Laukkanen JA
    Serum zinc concentrations and incident hypertension: new findings from a population-based cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  743. THOMAS HN, Evans GW, Berlowitz DR, Chertow GM, et al
    Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT).
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  744. SATOH M, Haga T, Hosaka M, Obara T, et al
    The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  745. LEMBO M, Esposito R, Lo Iudice F, Santoro C, et al
    Impact of pulse pressure on left ventricular global longitudinal strain in normotensive and newly diagnosed, untreated hypertensive patients.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  746. YANNOUTSOS A, Ahouah M, Tubiana CD, Topouchian J, et al
    Hemodynamic parameters in hypertensive diabetic patients.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  747. SENGUL S, Akpolat T, Erdem Y, Derici U, et al
    Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  748. LIANTONIO A, Imbrici P, Camerino GM, Fracchiolla G, et al
    Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  749. ZANCHETTI A
    Prognostic, diagnostic, and therapeutic advances in hypertension.
    J Hypertens. 2016.
    PubMed     Text format    


  750. PALATINI P, Rosei EA, Casiglia E, Chalmers J, et al
    Management of the hypertensive patient with elevated heart rate: statement of the second consensus conference endorsed by the European Society of Hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  751. SONAWANE KB, Qian J, Garza KB, Wright BM, et al
    Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation?
    J Hypertens. 2016;34:548-57.
    PubMed     Text format     Abstract available


  752. FERNALD FF, van den Born BJ, Snijder MB, Brewster LM, et al
    Hypertension awareness, treatment, and control among diabetic and nondiabetic individuals in a multiethnic population in the Netherlands: the HELIUS study.
    J Hypertens. 2016;34:539-47.
    PubMed     Text format     Abstract available


  753. BARZEL B, Lim K, Davern PJ, Burke SL, et al
    Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.
    J Hypertens. 2016;34:464-73.
    PubMed     Text format     Abstract available


  754. ZANCHETTI A
    Dietary, clinical and therapeutic aspects of hypertension.
    J Hypertens. 2016;34:371-2.
    PubMed     Text format    


  755. CHANG CH, Chiang CH, Yen CJ, Wu LC, et al
    Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
    J Hypertens. 2016;34:558-66.
    PubMed     Text format     Abstract available


  756. GRAHAM N, Smith DJ
    Comorbidity of depression and anxiety disorders in patients with hypertension.
    J Hypertens. 2016;34:397-8.
    PubMed     Text format    


    February 2016
  757. GOSMANOV AR, Lu JL, Sumida K, Potukuchi PK, et al
    Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  758. MECCARIELLO A, Buono F, Verrengia E, Orefice G, et al
    Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  759. WANG YK, Yu Q, Tan X, Wu ZT, et al
    Centrally acting drug moxonidine decreases reactive oxygen species via inactivation of the phosphoinositide-3 kinase signaling in the rostral ventrolateral medulla in hypertensive rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  760. LEHTONEN AO, Puukka P, Varis J, Porthan K, et al
    Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  761. TULLY PJ, Hanon O, Cosh S, Tzourio C, et al
    Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  762. GHAZI L, Dudenbostel T, Lin CP, Oparil S, et al
    Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  763. WANG IK, Chen JH, Muo CH, Chou CY, et al
    Subsequent risk of gout for women with hypertensive disorders in pregnancy: a retrospective cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  764. NIE X, Qin G, Mao W, Wang W, et al
    Axis inhibition protein 2 deficiency leads to hypoxic pulmonary hypertension through beta-catenin signaling pathway.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  765. KIKUCHI N, Jujo K, Yamaguchi J, Ogawa H, et al
    Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  766. ZANCHETTI A
    Prediction and prevention of hypertension-related events.
    J Hypertens. 2016.
    PubMed     Text format    


  767. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  768. MCLEAN G, Band R, Saunderson K, Hanlon P, et al
    Digital interventions to promote self-management in adults with hypertension systematic review and meta-analysis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  769. PIETILA-EFFATI PM, Salmela AK, Niemi RT, Ylitalo AS, et al
    Renal sympathetic denervation in treating drug-resistant hypertension in a patient on hemodialysis.
    J Hypertens. 2016;34:368-70.
    PubMed     Text format     Abstract available


  770. BOOTH JN 3RD, Muntner P, Abdalla M, Diaz KM, et al
    Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study.
    J Hypertens. 2016;34:235-43.
    PubMed     Text format     Abstract available


  771. YAO L, Folsom AR, Pankow JS, Selvin E, et al
    Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study.
    J Hypertens. 2016;34:196-203.
    PubMed     Text format     Abstract available


  772. REDON J
    The risk of visit-to-visit blood pressure variability in chronic kidney disease: cause or consequence.
    J Hypertens. 2016;34:188-90.
    PubMed     Text format    


  773. REDON J, Pichler G
    Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
    J Hypertens. 2016;34:359-67.
    PubMed     Text format     Abstract available


  774. KOTON S, Eizenberg Y, Tanne D, Grossman E, et al
    Trends in admission blood pressure and stroke outcome in patients with acute stroke and transient ischemic attack in a National Acute Stroke registry.
    J Hypertens. 2016;34:316-22.
    PubMed     Text format     Abstract available


  775. GRIFFIN TP, Browne GA, Wall D, Dennedy MC, et al
    A cross-sectional study of the effects of beta-blocker therapy on the interpretation of the aldosterone/renin ratio: can dosing regimen predict effect?
    J Hypertens. 2016;34:307-15.
    PubMed     Text format     Abstract available


  776. NORMAN G, Norton GR, Gomes M, Michel F, et al
    Circulating resistin concentrations are independently associated with aortic pulse wave velocity in a community sample.
    J Hypertens. 2016;34:274-81.
    PubMed     Text format     Abstract available


  777. MIDDLEMISS JE, Miles KL, McDonnell BJ, Yasmin, et al
    Mechanisms underlying elevated SBP differ with adiposity in young adults: the Enigma study.
    J Hypertens. 2016;34:290-7.
    PubMed     Text format     Abstract available


  778. SOUZA BDA S, Cunha DB, Pereira RA, Sichieri R, et al
    Soft drink consumption, mainly diet ones, is associated with increased blood pressure in adolescents.
    J Hypertens. 2016;34:221-5.
    PubMed     Text format     Abstract available


  779. BENEZET-MAZUECOS J, Iglesias JA, Cortes M, Vieja JJ, et al
    Silent brain infarcts in high blood pressure patients with cardiac implantable electronic devices: unmasking silent atrial fibrillation.
    J Hypertens. 2016;34:338-44.
    PubMed     Text format     Abstract available


  780. LURBE E, Ingelfinger JR
    Blood pressure in children and adolescents: current insights.
    J Hypertens. 2016;34:176-83.
    PubMed     Text format     Abstract available


  781. RIPHAGEN IJ, Gijsbers L, van Gastel MD, Kema IP, et al
    Effects of potassium supplementation on markers of osmoregulation and volume regulation: results of a fully controlled dietary intervention study.
    J Hypertens. 2016;34:215-20.
    PubMed     Text format     Abstract available


  782. CHANG TI, Tabada GH, Yang J, Tan TC, et al
    Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
    J Hypertens. 2016;34:244-52.
    PubMed     Text format     Abstract available


  783. VELASCO A, Ayers C, Das SR, de Lemos JA, et al
    Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.
    J Hypertens. 2016;34:226-34.
    PubMed     Text format     Abstract available


    January 2016
  784. LOPRINZI PD
    Accelerometer-determined physical activity and all-cause mortality in a national prospective cohort study of hypertensive adults.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  785. TADIC M, Cuspidi C, Pencic B, Andric A, et al
    The interaction between blood pressure variability, obesity, and left ventricular mechanics: findings from the hypertensive population.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  786. BLACK MH, Zhou H, Sacks DA, Dublin S, et al
    Hypertensive disorders first identified in pregnancy increase risk for incident prehypertension and hypertension in the year after delivery.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  787. ZANCHETTI A, Liu L, Mancia G, Parati G, et al
    Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
    J Hypertens. 2016.
    PubMed     Text format    


  788. ZDROJEWSKI T, Wizner B, Wiecek A, Slusarczyk P, et al
    Prevalence, awareness, and control of hypertension in elderly and very elderly in Poland: results of a cross-sectional representative survey.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  789. MULE G, Nardi E, Morreale M, D'Amico S, et al
    Relationship between aortic root size and glomerular filtration rate in hypertensive patients.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  790. KARATZI K, Georgiopoulos G, Yannakoulia M, Efthimiou E, et al
    Eating frequency predicts new onset hypertension and the rate of progression of blood pressure, arterial stiffness, and wave reflections.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  791. KIM SH, Kim YH, Kim JS, Lim SY, et al
    Target-organ damage and incident hypertension: the Korean genome and epidemiology study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  792. SANDSTROM YK, Ljunggren G, Wandell P, Wahlstrom L, et al
    Psychiatric comorbidities in patients with hypertension - a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  793. BRIASOULIS A, Androulakis E, Palla M, Papageorgiou N, et al
    White-coat hypertension and cardiovascular events: a meta-analysis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  794. HARDING JL, Sooriyakumaran M, Anstey KJ, Adams R, et al
    Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts.
    J Hypertens. 2016;34:149-55.
    PubMed     Text format     Abstract available


  795. MANCIA G, Omboni S, Chazova I, Coca A, et al
    Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    J Hypertens. 2016;34:139-48.
    PubMed     Text format     Abstract available


  796. SIVEN SS, Niiranen TJ, Kantola IM, Jula AM, et al
    White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
    J Hypertens. 2016;34:54-60.
    PubMed     Text format     Abstract available


  797. PARK JS, Jung I, Youn JC, Cho HY, et al
    Impact of adolescent pregnancy on hypertension in postmenopausal women.
    J Hypertens. 2016;34:47-53.
    PubMed     Text format     Abstract available


  798. LI W, Gu H, Teo KK, Bo J, et al
    Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China.
    J Hypertens. 2016;34:39-46.
    PubMed     Text format     Abstract available


  799. GALAN M, Salaices M
    T-regulatory cells and vascular function: the importance of their immunosuppressive action in hypertensive disease.
    J Hypertens. 2016;34:36-8.
    PubMed     Text format    


  800. HE J
    Hypertension in China: a large and increasing public health challenge.
    J Hypertens. 2016;34:29-31.
    PubMed     Text format    


  801. BISOGNI V, Rossitto G, Reghin F, Padrini R, et al
    Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders.
    J Hypertens. 2016;34:20-8.
    PubMed     Text format     Abstract available


  802. MIAN MO, Barhoumi T, Briet M, Paradis P, et al
    Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.
    J Hypertens. 2016;34:97-108.
    PubMed     Text format     Abstract available


  803. JUHANOJA EP, Niiranen TJ, Johansson JK, Puukka PJ, et al
    Agreement between ambulatory, home, and office blood pressure variability.
    J Hypertens. 2016;34:61-7.
    PubMed     Text format     Abstract available


    December 2015
  804. MODESTI PA, Omboni S, Taddei S, Ghione S, et al
    Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  805. LINHART C, Tukana I, Lin S, Taylor R, et al
    Continued increases in hypertension over three decades in Fiji, and the influence of obesity.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  806. KOTSIS V, Grassi G
    The enigma of obesity-induced hypertension mechanisms in the youth.
    J Hypertens. 2015.
    PubMed     Text format    


  807. PRZEWOZNY T, Gojska-Grymajlo A, Kwarciany M, Graff B, et al
    Hypertension is associated with dysfunction of both peripheral and central auditory system.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


    November 2015
  808. HU J, Wang Y, Xiang X, Peng C, et al
    Serum bisphenol A as a predictor of chronic kidney disease progression in primary hypertension: a 6-year prospective study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  809. ZANCHETTI A
    From risk factors to treatment of hypertension.
    J Hypertens. 2015.
    PubMed     Text format    


  810. FORST T, Michelson G, Diessel S, Jahnke J, et al
    Microvascular effects of the inhibition of dipeptidylpeptidase IV by linagliptin in nondiabetic hypertensive patients.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  811. HUERTA A, Lopez B, Ravassa S, Jose GS, et al
    Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


    October 2015
  812. NILSSON PM
    Blood pressure control in type 2 diabetes over time - what can we learn from different trajectories?
    J Hypertens. 2015;33:2018-9.
    PubMed     Text format    


    July 2015
  813. WALRAVEN I, Mast MR, Hoekstra T, Jansen AP, et al
    Real-world evidence of suboptimal blood pressure control in patients with type 2 diabetes.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  814. SALMAN IM, Phillips JK, Ameer OZ, Hildreth CM, et al
    Abnormal central control underlies impaired baroreflex control of heart rate and sympathetic nerve activity in female Lewis polycystic kidney rats.
    J Hypertens. 2015;33:1418-28.
    PubMed     Text format     Abstract available


  815. BURNIER M
    Urinary angiotensinogen and salt sensitivity of blood pressure: the challenge of finding biomarkers of salt-sensitivity.
    J Hypertens. 2015;33:1368-70.
    PubMed     Text format    


  816. PARATI G, Zhang Y
    Assessing blood pressure response to exercise: methodological issues and clinical relevance.
    J Hypertens. 2015;33:1364-7.
    PubMed     Text format    


  817. WANG D, Wang C, Zhou Y, Wang A, et al
    Different blood pressure indexes on intracranial arterial stenosis in Asymptomatic Polyvascular Abnormalities in Community study in China.
    J Hypertens. 2015;33:1452-7.
    PubMed     Text format     Abstract available


  818. SERAVALLE G, Lonati L, Buzzi S, Cairo M, et al
    Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states.
    J Hypertens. 2015;33:1411-7.
    PubMed     Text format     Abstract available


  819. VERGER A, van der Gucht A, Guedj E, Marie PY, et al
    Central pulse pressure is a determinant of heart and brain remodeling in the elderly: a quantitative MRI and PET pilot study.
    J Hypertens. 2015;33:1378-85.
    PubMed     Text format     Abstract available


  820. REBHOLZ CM, Chen J, Zhao Q, Chen JC, et al
    Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure.
    J Hypertens. 2015;33:1394-400.
    PubMed     Text format     Abstract available


  821. CUNHA PG, Cotter J, Oliveira P, Vila I, et al
    Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging.
    J Hypertens. 2015;33:1438-45.
    PubMed     Text format     Abstract available


  822. RUBATTU S, Di Castro S, Cotugno M, Bianchi F, et al
    Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPARalpha/UCP2 axis.
    J Hypertens. 2015;33:1465-79.
    PubMed     Text format     Abstract available


    June 2015
  823. MARTELL-CLAROS N, Abad-Cardiel M, Alvarez-Alvarez B, Garcia-Donaire JA, et al
    Primary aldosteronism and its various clinical scenarios.
    J Hypertens. 2015;33:1226-32.
    PubMed     Text format     Abstract available


  824. MOREO A, Gaibazzi N, Faggiano P, Mohammed M, et al
    Multiparametric carotid and cardiac ultrasound compared with clinical risk scores for the prediction of angiographic coronary artery disease: a multicenter prospective study.
    J Hypertens. 2015;33:1291-300.
    PubMed     Text format     Abstract available


  825. ANENI EC, Oni ET, Martin SS, Blaha MJ, et al
    Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk.
    J Hypertens. 2015;33:1207-14.
    PubMed     Text format     Abstract available


  826. TRACHSEL LD, Carlen F, Brugger N, Seiler C, et al
    Masked hypertension and cardiac remodeling in middle-aged endurance athletes.
    J Hypertens. 2015;33:1276-83.
    PubMed     Text format     Abstract available


  827. MENNI C
    Blood pressure pharmacogenomics: gazing into a misty crystal ball.
    J Hypertens. 2015;33:1142-3.
    PubMed     Text format    


  828. JORDAN J, Grassi G
    Natriuretic peptides in the cross-talk of human cardiovascular and metabolic regulation.
    J Hypertens. 2015;33:1139-41.
    PubMed     Text format    


  829. VAN HATEREN KJ, Hendriks SH, Groenier KH, Bakker SJ, et al
    Frailty and the relationship between blood pressure and mortality in elderly patients with type 2 diabetes (Zwolle Outpatient Diabetes project Integrating Available Care-34).
    J Hypertens. 2015;33:1162-6.
    PubMed     Text format     Abstract available


    April 2015
  830. DRAMAN MS, Dolan E, van der Poel L, Tun TK, et al
    The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  831. PETRAMALA L, Violi F, Letizia C
    Response to 'Oxidative stress in patients affected by primary aldosteronism'.
    J Hypertens. 2015;33:884.
    PubMed     Text format    


  832. SAMBHI MP
    Oxidative stress in patients affected by primary aldosteronism.
    J Hypertens. 2015;33:883.
    PubMed     Text format    


    January 2015
  833. PARK HY, Kim JH, Bae S, Choi YY, et al
    Interaction effect of serum 25-hydroxyvitamin D levels and CYP1A1, CYP1B1 polymorphisms on blood pressure in an elderly population.
    J Hypertens. 2015;33:69-76.
    PubMed     Text format     Abstract available


  834. STABOULI S, Papakatsika S, Kotronis G, Papadopoulou-Legbelou K, et al
    Arterial stiffness and SBP variability in children and adolescents.
    J Hypertens. 2015;33:88-95.
    PubMed     Text format     Abstract available


  835. MACDONALD-WALLIS C, Silverwood RJ, Fraser A, Nelson SM, et al
    Gestational-age-specific reference ranges for blood pressure in pregnancy: findings from a prospective cohort.
    J Hypertens. 2015;33:96-105.
    PubMed     Text format     Abstract available


    September 2013
  836. SALLES GF , Leite NC, Pereira BB, Nascimento EM, et al
    Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    J Hypertens. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: